Carpal tunnel syndrome: aspects of diagnosis and outcome by Claes, J.F.H.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/134503
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.

Copyright©2014 Franka Claes
ISBN  978-90-9028659-4
Printed by Ipskamp Drukkers, Enschede
Design by Legatron electronic Publishing, Rotterdam
Cover design by Studio Steur, Rotterdam
All rights reserved. No part of this thesis may be reproduced, stored in a retrieval system, 
or transmitted in any form or by any means, without prior written permission of the 
author, or when appropriate, of the publishers of the publications included in this thesis.
CARPAL TUNNEL SYNDROME
ASPECTS OF DIAGNOSIS AND OUTCOME
PROEFSCHRIFT
Ter verkrijging van de graad van doctor
aan de Radboud Universiteit Nijmegen
op gezag van de rector magnificus prof. dr. Th.L.M. Engelen,
volgens besluit van het college van decanen
in het openbaar te verdedigen op donderdag 22 januari 2015
om 12.30 uur precies
door
Franka Claes
geboren op 25 oktober 1976
te Weert
Promotor Prof. dr. J.A. Grotenhuis
Copromotoren  Dr. W.I.M. Verhagen (CWZ)
 Dr. J.Meulstee (CWZ)
Manuscriptcommissie Prof. dr. B.G.M. van Engelen
 Prof. dr. D.J.O. Ulrich
 Prof. dr. L.H. Visser (Universiteit voor Humanistiek / 
 St. Elisabeth Ziekenhuis)
 Dr. R.H.M.A. Bartels
 Dr. N. van Alfen
Contents
Chapter 1 General introduction and outline 7
Chapter 2 Carpal tunnel syndrome diagnosed by general practitioners:  19 
 an observational study
Claes F, Bernsen H, Meulstee J, Verhagen WIM.  
Neurol Sci 2012;33:1079-81
Chapter 3 Current practice in the use of nerve conduction studies in  29
 carpal tunnel syndrome by surgeons in the Netherlands
Claes F, Verhagen WIM, Meulstee J.  
J Hand Surg Eur Vol 2007;32:663-7 
Chapter 4 Usefulness of additional measurements of the median nerve  43 
 with ultrasonography
Claes F, Meulstee J, Claessen-Oude Luttikhuis TT, Huygen PLM,  
Verhagen WIM. Neurol Sci 2010;31:721-5
Chapter 5 Comparing a new ultrasound approach with electrodiagnostic  57 
 studies to confirm clinically defined carpal tunnel syndrome
Claes F, Kasius KM, Meulstee J, Verhagen WIM.  
Am J Phys Med Rehabil 2013;92:1005-11
Chapter 6 Treatment outcome in carpal tunnel syndrome:  73 
 does distribution of sensory symptoms matter?
Claes F, Kasius KM, Meulstee J, Grotenhuis JA, Verhagen WIM.  
J Neurol Sci 2014;344 :143-8
Chapter 7 Ultrasonography in severe carpal tunnel syndrome 93
Kasius KM, Claes F, Verhagen WIM, Meulstee J.  
Muscle Nerve 2012;45:334-7
Chapter 8 Summary, general discussion and perspectives 107
Chapter 9 Nederlandse samenvatting 123
Chapter 10 Appendices 133
  Vragenlijst 135
  Abbreviations  137
  Dankwoord 139
  List of publications 143
  Curriculum vitae 145
Chapter 1
General introduction and outline

91
General introduction and outline
Carpal tunnel syndrome
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy and 
is caused by compression of the median nerve in the carpal tunnel. Diagnosis is 
based upon patient history and neurologic examination and is often confirmed 
by electrodiagnostic examination (EDX).1,2,3 Prevalence of undetected CTS is 5.8% 
among women and 0.6% among men in the general population of the Netherlands.4 
Other studies found a prevalence of clinically and electrodiagnostically diagnosed 
CTS of 2.1% in men and 3.0% in women in all age groups, with the highest prevalence 
between 55-64 years in men and 65-74 years in women.5 Over the past decades, 
referral for hand complaints, and in particular for complaints suggestive of CTS, 
has increased significantly. Wildin et al. showed referrals for CTS operation from 
primary care had almost doubled in the period 2000-2001, compared to 1989-
1990.6 Treatment consists of conservative measures, such as splinting, local steroid 
injection at the carpal tunnel, or surgical decompression by an open or endoscopic 
procedure.7,8,9
 Patients with CTS typically complain of paresthesia, numbness and pain in the 
territory innervated by the median nerve: the palmar side and fingertips of digits 
1 to 3 and the medial side of digit 4. Paresthesia often awake patients during the 
night and are typically provoked by using a telephone, holding a book or driving a 
car. Frequently, patients report relief of symptoms by shaking the hand (Flick sign10) 
or holding it in a dependent position. Neurologic examination is often normal in 
patients with CTS. However, reduced grip strength or loss of digital sensibility 
with Semmes-Weinstein monofilament may be present, as well as, in more severe 
cases, thenar atrophy. Neurologic examination can, to a large extent, exclude 
other known causes of paresthesia in the hand, such as cervical radiculopathy, 
polyneuropathy, brachial plexopathy or ulnaropathy. On the basis of these clinical 
signs and symptoms, a definite clinical diagnosis of CTS can be made. However, in 
the Netherlands, most physicians feel the need to have the diagnosis confirmed by 
electrodiagnostic examination (EDX), i.e. showing conduction abnormalities of the 
median nerve across the carpal tunnel.1,2,3 
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With a sensitivity of 85 to 90% and a specificity of 95%,1 EDX is obviously not the 
gold standard in diagnosing CTS. The most recent Dutch Consensus Guideline 
for diagnosis and treatment of carpal tunnel syndrome recommends verifying 
a clinical diagnosis of CTS with electrodiagnostic studies if surgical treatment 
is considered.3 However, there is debate about the need for electrodiagnostic 
confirmation in diagnosing CTS. Some authors state that nerve conduction studies 
contribute little to the diagnosis in typical cases of CTS.11,12,13 Others state that the 
use of EDX is mandatory to confirm the clinical diagnosis, to exclude the diagnosis 
of polyneuropathy or other compressive neuropathies or to provide a baseline for 
comparison if surgery fails and to classify severity of median neuropathy.14 In some 
studies, up to 34% of false negative electrodiagnostic studies were reported.15 
Therefore, in daily clinical practice the use of electrodiagnostic studies in diagnosing 
CTS may differ among clinicians. 
 Electrodiagnostic studies have other limitations besides a suboptimal sensitivity 
and specificity: many patients find the examinations inconvenient, uncomfortable 
or even painful. Moreover, electrodiagnostic studies have the limitation of not 
providing any anatomical information of the median nerve or the content of the 
carpal tunnel. The last few years, many studies were published on ultrasonography 
in diagnosing CTS.16,17,18 Ultrasonography is an easy accessible, non-invasive, 
patient-friendly examination, that can pre-operatively give relevant information on 
the content of the carpal tunnel.
 Buchberger et al. were the first to describe results of the use of high-resolution 
ultrasonography in carpal tunnel syndrome.19 Technological evolvement has 
improved spatial resolution, using high-frequency transducers that can image 
superficially localized structures, like the median nerve at the wrist, more accurately. 
Several features have been found to be characteristic of carpal tunnel syndrome: 
(1) increase in cross-sectional area (CSA) at the level of the pisiform bone and, to a 
lesser extent, at the level of the hamate; (2) significant increase in cross-sectional 
area at the level of the pisiform bone compared to the cross-sectional area at the 
level of the distal radius (swelling ratio); (3) significant increase in the flattening 
ratio at the level of the hook of the hamate; and (4) significant palmar bowing of 
the flexor retinaculum.16 The cross-sectional area at or just before the carpal tunnel 
11
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inlet appeared to be the most consistent finding, although there is still discussion 
about the most appropriate level of measurement20 (Figure 1 and 2).
Figure 1. Example of transverse ultrasonographic study of the median nerve at the inlet 
of the carpal tunnel. The median nerve is indicated by tracing the inside margin of the 
hyperechoic sheath of the nerve. 
Figure 2. Longitudinal ultrasonographic view of the median nerve at the wrist. The median 
nerve is indicated by four marks. 
12
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Diagnostic accuracy of sonography in diagnosing CTS varies between studies. 
Several reviews have been published on this topic.16,21,22 In the most recent meta-
analysis, a cut-off value of the CSA of 9 mm2 is the best single diagnostic criterion, 
with sensitivity 87.3% and specificity 83.3%.23 However, because of a lack of 
standardization of sonographic techniques used, as well as different sample size 
and different study design, wide variations of sensitivity and specificity occur and 
conclusions are limited.
 External factors, such as prolonged postures in extremes of wrist flexion or 
extension, repetitive use of the flexor muscles and exposure to vibration, are 
associated with CTS.24 Beside these external factors, other (medical) conditions 
are related to occurrence of CTS. These include obesity, hypothyroidism, diabetes 
mellitus and pregnancy. Increase in volume of the carpal tunnel is believed to be 
one of the causes. In patients with diabetes there is increased risk of neuropathies 
in general.25,26 It has also been stated that wrist anthropometrics are related to the 
occurrence of CTS and some studies showed that a more squarely shaped wrist is 
associated with carpal tunnel syndrome.27,28 
 
Aims and outline of this thesis
Many clinicians agree that the diagnosis CTS is mainly a clinical one. However, in 
many guidelines, supplementary electrodiagnostic examination before operative 
treatment is recommended.3 However, EDX is not the gold standard in diagnosing 
CTS and there is discussion on the need for EDX in daily clinical practice. Also, 
newer, easy accessible diagnostic tools such as ultrasonography are studied and 
used with increasing frequency.
 The overall subject of this thesis is to investigate current daily clinical practice in 
diagnosing and treating CTS patients, and to find out whether ultrasonography can 
diagnose CTS with the same accuracy as EDX. Since surgical treatment is performed 
in many patients with severe complaints of CTS, the opinions and ideas of surgeons 
on diagnostic criteria in CTS are important and interesting. With the controversy on 
the need for electrodiagnostic confirmation of the clinical diagnosis CTS in mind, 
13
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we sent questionnaires to all surgeons in the Netherlands who operate on CTS 
patients. The results of this study are presented in chapter 3. We evaluated the 
opinion of different surgical disciplines with regard to the need for electrodiagnostic 
testing in order to confirm the diagnosis CTS and also to find out to what extent 
patients with clinically defined CTS are still operated on without electrodiagnostic 
confirmation. 
 Nowadays, service to patients and cost-efficiency are important subjects to 
consider in organising health care services. In the Netherlands, general practitioners 
have been allowed to refer patients with suspected CTS directly to a department 
of Clinical Neurophysiology for the last few years. In a one-stop mode patients are 
evaluated by a neurologist, undergo diagnostic investigation and are, if necessary, 
referred for further evaluation by a surgeon. Besides saving patients further visits 
to the hospital, this also means a significant improvement in cost-effectiveness. In 
chapter 2 the results of an observational study , designed to answer the question 
to what extent a neurologist agrees with the clinical diagnosis as stated by the 
general practitioner, are presented. We investigated the results of both clinical 
testing and standardized nerve conduction studies performed in patients with 
suspected carpal tunnel syndrome, who were referred for further analysis by their 
general practitioner.
 Chapter 4 shows the results of a study of control subjects, intending to develop 
normal values for high-frequency ultrasonography in the diagnosis of CTS. Since 
results of sonographic studies are operator dependent, it is important to establish 
normal values in each laboratory separately. We aimed to establish normal values 
for the median nerve CSA at the inlet of the carpal tunnel and to investigate the value 
of measuring additional parameters. Various biophysical parameters, including age, 
gender, height and wrist circumference were measured and BMI was calculated. 
We investigated whether a possible correlation with CSA could be found, in order 
to establish the upper limit of normal more accurately. We hypothesized that wrist 
circumference is associated with CSA of the median nerve and that normal values 
of CSA depend on the wrist circumference of a given patient.
 With normal values, taking wrist circumference into account, we investigated 
whether EDX can be replaced by ultrasonography to confirm CTS. We performed a 
14
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prospective, blinded study comparing the results of this new ultrasound approach 
with results of EDX in confirming clinically defined CTS. The results of this study are 
discussed in chapter 5. We explored the question, whether it is justified to perform 
EDX only in CTS patients with normal sonographic test results. 
 It is well-known that many patients with CTS do not have the classic distribution 
of symptoms. For instance, many patients experience sensory symptoms outside 
the median nerve territory, for example in the whole hand.29,30,31 It is unclear, 
whether patients with otherwise typical CTS complaints, but additional sensory 
symptoms in digit 5 should be treated with the same procedure as patients with 
a ‘classic’ distribution of symptoms of CTS meaning solely confined to the median 
nerve innervated area. 
 To learn more on the outcome of patients with CTS with acroparesthesia not 
exclusively confined to the median nerve innervated area and with involvement of 
digit 5 we performed a study to compare outcome measures in patients with ‘classic’ 
versus ‘non-classic’ CTS complaints. As we investigated earlier, some surgeons do 
not require confirmation of a clinical diagnosis CTS before operating CTS patients. In 
the Netherlands, guidelines recommend electrodiagnostic confirmation of clinical 
CTS when considering operative treatment.3 However, in patients with ’non-classic’ 
location of sensory symptoms, hesitation to operate may exist even if EDX results 
support the diagnosis. Chapter 6 describes the results of a prospective cohort study 
to investigate the question whether patients with characteristic CTS complaints 
but symptoms not solely confined to the median nerve innervated area, which in 
addition were electrodiagnostically confirmed, benefit from treatment to the same 
extent as patients who do fit ‘classic’ clinical CTS criteria. 
 We used strict inclusion criteria to study a group of subjects as uniformly as 
possible in the studies mentioned above. One of our exclusion criteria was the 
presence of severe thenar atrophy. We assumed that patients with severe CTS 
form a distinct group with different electrodiagnostic and ultrasonographic 
features. Presence of severe thenar atrophy is often a sign of severe CTS. In up 
to 30% of patients with CTS, the CSA of the median nerve is not enlarged.16 We 
hypothesized that this could be the result of secondary atrophy of the nerve in 
severe CTS. Previous studies demonstrated that, in CTS patients, the degree of 
15
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electrophysiological abnormalities is associated with CSA of the median nerve at 
the wrist32,33 The aim of the prospective cohort study presented in chapter 7 is to 
measure the ultrasonographic CSA of the median nerve at the wrist in patients with 
severe CTS. 
 Chapter 8 provides a summary of our results, general discussion and future 
directions for research are proposed.
16
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Abstract
The aim of this study was to investigate the results of both clinical testing and 
standardised nerve conduction studies performed on patients with carpal tunnel 
syndrome (CTS) complaints, who had been referred to the neurologist by their 
general practitioners. Analysis of the data of neurological examination and 
electrodiagnostic tests (EDX) were performed on patients that had been referred 
by general practitioners. A total of 232 patients with clinically defined CTS, who 
had been referred by general practitioners, were seen by a neurologist and 
subsequently underwent electrodiagnostic testing. The diagnosis of CTS made by 
general practitioners was clinically confirmed by the neurologist in 187 out of 232 
(81%) patients. In these 187 patients, EDX confirmed CTS clinical diagnosis in 180. 
In 40 (17%), the neurologists disagreed with the clinical diagnosis of CTS because 
signs and symptoms were not those of clinical CTS. We showed that general 
practitioners are very well capable of making a clinical diagnosis of CTS. Therefore, 
direct referral of patients by general practitioners for nerve conduction studies to 
have their diagnosis of CTS confirmed is a desirable and time-saving procedure. 
22
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Introduction
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy. 
Reported population-based prevalence is 5.8% in women and 0.6% in men.1 
Epidemiology in general practice studies shows an incidence of 2.8 per 1,000 in 
women and 0.9 per 1,000 in men.2 Carpal tunnel decompression is frequently 
performed: almost 3,000 cases per year in a population of 5 million people.3 It is 
to be expected that the number of referrals will increase even further.4 General 
practitioners are more aware of available treatments, patients’ thresholds for 
registering complaints are lower, and workers are encouraged to seek assessments 
to validate claims for compensation. The signs of CTS with typical nocturnal 
paresthesias in the median nerve area usually permit a diagnosis solely based on 
clinical signs and symptoms. However, most of the time, electrodiagnostic studies 
(EDX) are performed, in order to confirm the diagnosis.5,6 In the Netherlands EDX 
is performed in a department of clinical neurophysiology only after careful clinical 
examination by a specialist; general practitioners do not have the opportunity to 
ask an EDX directly. However, for reasons of practicality and economy, it might 
be an option that general practitioners refer patients directly to neurophysiology 
departments too, if they are able to make a correct clinical diagnosis. 
 The present study’s aim was to investigate whether general practitioners 
could refer patients with CTS complaints directly for EDX, i.e. without consulting 
a neurologist. All patients in the present study were referred to a neurologist 
(HB) by their general practitioner, and were tested with prospectively chosen and 
standardised electrodiagnostic tests. 
Methods
Two hundred and thirty-two patients, who had been referred by general 
practitioners with clinically defined CTS in the period June 2007 to January 2009, 
were included in the study. In case of suspected CTS general practitioners were 
asked to provide a checklist-like referral letter including the CTS criteria mentioned 
23
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below to enable administrative personnel to recognise and redirect referral directly 
to the specialised CTS outpatient clinic. The advantage is that patients will be 
served better by combining clinical and EDX testing during the same hospital visit.
CTS was considered present in patients with pain and/or paresthesia in and 
restricted to the sensory distribution of the median nerve for at least 3 months, 
and if patients met 2 or more of the following criteria: (1) nocturnal paresthesias, 
(2) reproduction or aggravation of paresthesias or pain by provocative tests (Tinel 
or Phalen’s sign), (3) aggravation of paresthesias by activities such as car driving, 
bicycling, holding a book, or holding a telephone, and (4) relieve of symptoms by 
shaking the hand (Flick sign), excluding patients with hand trauma, polyneuropathy, 
central nervous system disorders, cervical radiculopathy, previous surgery for CTS, 
atypical complaints.7 These clinical criteria have been used in other studies.8 
 In every patient, signs and symptoms were evaluated, and the neurologist 
performed a full neurological examination. The neurologist made a clinical 
diagnosis based on signs and symptoms, and his neurological examination, before 
performing the conduction tests. EDX was performed in order to see whether the 
clinical diagnosis of both the general practitioner and the neurologist could be 
confirmed. The gold standard was the clinical diagnosis.
 All patients were tested electrodiagnostically, using standardised techniques.5 
During the test procedure, skin temperature was maintained at at least 31°C. At 
least three separate tests were performed as follows: first, distal sensory latency 
difference in the fourth finger between ulnar and median stimulation at the wrist 
(difference distal sensory latency DSL > 0.4 ms); second, between the radial and 
median nerve in the thumb after stimulation at the wrist (difference DSL > 0.6 ms); 
and third, a comparison of the nerve conduction velocity in median nerve at the 
wrist with that from proximal and distal located segments (forearm and finger, 
respectively) (difference > 10 or 15 m/s, respectively). If no sensory potentials could 
be obtained, the distal motor latency (DML) of the median nerve (thenar muscles) 
was determined (DML > 4.0 ms). The clinical diagnosis of CTS was confirmed when 
two or more electrodiagnostic tests were abnormal.
 When clinical signs and symptoms were typical of CTS and nerve conduction 
studies were normal, the diagnosis was based on clinical grounds. The diagnosis 
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of possible CTS was made in patients with complaints not restricted to the median 
nerve area (paraesthesia and/or pain also in the fifth finger), but otherwise fulfilling 
the criteria mentioned above.
Results
Included were 232 patients, who were referred by their general practitioner with 
a clinical diagnosis of CTS. In 187 (81%) cases, the diagnosis was confirmed on 
clinical grounds by the neurologist. In 40 (17%) cases the neurologist disagreed 
with the diagnosis of the general practitioner; 2 patients turned out to have an 
ulnar neuropathy and 33 patients had no signs or symptoms of any neuropathy al 
all. In 5 patients, not all clinical criteria as described in the methods section fulfilled 
the necessary number of criteria for the diagnosis CTS and were categorised as 
“possible CTS”; therefore, the diagnosis of CTS was abandoned in this group.
 With EDX the clinical diagnosis of CTS could be confirmed in 180 cases (78%); 
7 patients with clinically defined CTS had normal test results (4%). Two patients 
with clinical signs and symptoms of ulnar neuropathy could be confirmed 
electrodiagnostically. Fifty patients had normal electrodiagnostic test results. 
Results are summarized in Table 1.
Table 1. Agreement between clinical diagnosis by general practitioner (GP) and neurologist 
in combination with nerve conduction studies (NCS)  
CTS according to GP n = 232
CTS Possible CTS No CTS
Neurologist clinical diagnosis 187 (81%) 5 (2%) 40 (17%)
NCS CTS 180 (78%) 0 (0%) 0 (0%)
NCS no CTS 7 (3%) 5 (2%) 40 (17%)
25
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Discussion
CTS is a frequently occurring and effectively treatable nerve entrapment syndrome. 
Treatment may consist of splinting, a corticosteroid injection in the carpal tunnel 
or transection of the carpal ligament. CTS complaints are very inconvenient for 
the patient, often disturbing work and sleep. Therefore, a quick and accurate 
diagnosis is important. The diagnosis of carpal tunnel syndrome is usually based 
on history, and clinical signs and symptoms. In the Netherlands, patients with CTS 
complaints turn to their general practitioner, who then refers them to a neurologist 
for confirmation of the diagnosis. Mostly, EDX is performed,9 as is preferred by 
Dutch surgeons.6
 In the Netherlands electrodiagnostic examination is performed only after 
careful clinical examination by a medical specialist. Until now, general practitioners 
are not able to request an EDX for CTS without intervention of a neurologist. 
However, intervention by a neurologist may obviously cause an undesirable delay. 
This delay could be eliminated if general practitioners refer CTS patients directly 
for surgery or for application of conservative treatment. In order to see if it is 
feasible to pass over the neurologist, we investigated the concordance between 
the clinical diagnosis of CTS made by the general practitioner and the diagnosis 
of an experienced neurologist. We have chosen to keep the studied population 
as homogeneous as possible and excluded CTS patients with symptoms outside 
the median nerve territory. Therefore, the conclusions are only applicable to CTS 
patients with “classic” distribution of the symptoms.
 It turned out that in only 17% out of the 232 patients, the neurologist disagreed 
with the clinical diagnosis of CTS as made by the general practitioner. In our opinion 
this difference can be explained by the specific expertise of a neurologist, especially 
by more extensive knowledge of differential diagnosis. However, even between 
experienced neurologists there can be also some differences in the interpretation. 
An interrater reliability study between neurologists was not the aim of this study. 
It would have been interesting to know what the results had been when general 
practitioners were also allowed to refer patients with the diagnosis possible/
probable CTS.
26
Chapter 2
None of the 40 patients in whom the diagnosis of CTS could not be clinically 
established had abnormal nerve conduction studies. This is remarkably high and 
may suggest that the neurologist was biased by the results of EDX. However, as 
stated before, the clinical diagnosis was made prior to EDX. EDX can be normal in 
mild CTS, and in some reports, false negative nerve conduction testing up to 34% 
is mentioned.5,8 In our group, 7 of 187 patients with clinical CTS had normal nerve 
conduction tests. These were diagnosed as having CTS and treated as such. 
 We found only a few studies compatible with our study. Mondelli et al.10 found 
in a group of 671 patients with clinical suspected CTS who were sent to the EMG 
service by general practitioners that the clinical diagnosis of CTS was considered 
correct by the neurophysiologist in 520 cases (77.5%). This result is very close to 
our findings (81%). Podnar11 also performed a study on referral diagnosis of general 
practitioners in a neurophysiology department. The clinical criteria for CTS are not 
mentioned. CTS was confirmed electrodiagnostically in 60% of the patients. There 
are no data on the clinical diagnosis of the neurophysiologist alone (ie before 
electrodiagnostic studies).
 Electrodiagnostic confirmation of the clinical diagnosis CTS will remain 
desirable; therefore, it could be considered to have general practitioners refer 
patients directly for electrodiagnostic studies prior to treatment, at least surgical 
treatment.
 In conclusion, our results show that for many patients suspected to have CTS 
according to strict defined criteria, direct referral for EDX after clinical evaluation 
by general practitioners, is a quick and useful way to confirm the clinical diagnosis 
CTS. General practitioners are well capable of diagnosing CTS, following the low 
percentage of wrong diagnoses in this study (17%). Direct referral by general 
practitioners to neurophysiology departments for EDX to confirm the diagnosis 
saves time and reduces costs. 
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Abstract
The current practice in and the opinion about the treatment of carpal tunnel 
syndrome by surgeons in the Netherlands was evaluated in respect of the extent 
to which electrodiagnostic studies are used or needed to confirm the diagnosis. 
Questionnaires were sent to all Dutch surgeons who operate on patients with 
carpal tunnel syndrome. The response rate was 47% (324 out of 686). The 
majority of neurosurgeons and orthopaedic surgeons seldom operate without 
electrodiagnostic confirmation in line with the Dutch consensus guideline on this 
subject. In contrast, plastic surgeons operate more often on patients with clinically 
defined carpal tunnel syndrome even with normal electrodiagnostic studies. 
Knowledge of these strikingly different diagnostic and therapeutic strategies and 
opinions may influence diagnostic and referral behaviour of clinical neurologists 
and others.
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Introduction
Carpal tunnel syndrome (CTS) causing compression of the median nerve within the 
carpal tunnel is the most common entrapment neuropathy. The clinical diagnosis 
is based on a history of pain, paraesthesiae and numbness in the palmar surfaces 
and tips of the fingers innervated by the median nerve. Various clinical tests are 
available to help make a diagnosis. However, these are not very specific.1,2,3,4 
Unfortunately, a gold standard for the diagnosis CTS does not exist and, often, 
electrodiagnostic studies are performed to help confirm the diagnosis. 
 However, there exists a significant body of patients with typical complaints of 
carpal tunnel syndrome, in whom electrodiagnostic studies are negative. In the 
second literature review published by the American Association of Electrodiagnostic 
Medicine,5 it was concluded that median sensory and motor nerve conduction 
studies confirm a clinical diagnosis of CTS with a sensitivity of more than 85%. This 
identifies that the tests are not absolute in allowing a diagnosis of this condition to 
be made. 
 In the Netherlands, patients with CTS complaints are often seen initially by 
a neurologist. When CTS is diagnosed, both clinically and electrodiagnostically, 
and an operation is indicated, the neurologist refers the patient to a surgeon. 
In general, CTS surgery is performed by neurosurgeons, orthopaedic surgeons 
and plastic surgeons. In addition, an undetermined number of CTS patients are 
referred to a surgeon directly by their general practitioner. Recently, the Dutch 
Institute for Healthcare Improvement (CBO), published a consensus guideline on 
treatment of CTS.6 The Dutch Associations of Neurology, Surgery, Plastic Surgery 
and Neurosurgery all participated in the development of this guideline. In this 
consensus guideline, the advice was to perform an open release of the carpal 
tunnel only when electrodiagnostic tests have confirmed the clinical diagnosis 
of CTS. When electrodiagnostic studies are normal, conservative treatment was 
recommended.
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With the controversies existing about the need for electrodiagnostic studies 
confirming the diagnosis of CTS, it would be interesting to know the opinion of 
surgeons operating on patients with CTS.
 The objective of this study is to evaluate the opinion of different surgical 
disciplines in regard of the need for electrodiagnostic testing for confirmation of 
the diagnosis CTS and to what extent patients with clinically defined CTS without 
electrodiagnostic confirmation are still operated on. 
Materials and methods
To evaluate the current practice in planning surgical treatment of clinically defined 
CTS by surgeons, with or without the use of electrodiagnostic studies to confirm 
the diagnosis, a questionnaire (Table 1) was sent to neurosurgeons, orthopaedic 
surgeons and plastic surgeons in the Netherlands. The surgical departments of 
all hospitals in the Netherlands were targeted. A stamped and addressed return 
envelope was included. Eventually, 686 surgeons received the questionnaire 
personally. Among them were 110 neurosurgeons, 417 orthopaedic surgeons and 
159 plastic surgeons. The questionnaire assessed the number of patients tested 
electrodiagnostically and the number of patients on whom surgery for CTS was 
carried out by the surgeons, or residents supervised by them. The next questions 
assessed the likelihood one would operate on CTS patients in different possible 
subsets.
 In general, carpal tunnel release in the Netherlands is performed most frequently 
by neurosurgeons, followed by plastic surgeons and orthopaedic surgeons. Most 
orthopaedic surgeons are general orthopaedic surgeons, operating also on CTS 
patients.
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Table 1. The questionnaire sent to Dutch surgeons
1. How many patients with carpal tunnel syndrome do you operate on each year?
0-50 51-100 101-150 151-200 201-250 251-300
301-350 351-400 401-450 451-500 more than 500 
2. How many of these patients do you operate on yourself and how many are 
being operated on by residents under your supervision?
Yourself (%) Supervision (%) 
3. How many of these patients underwent electrodiagnostic studies?
0-20% 21-40% 41-60% 61-70% 71-90% 91-95% 96-100% 
4. Do you operate on patients with typical CTS complaints, but normal electrodiagnostic studies 
and no response to conservative treatment?
never seldom often always 
5. Do you operate on patients with typical CTS complaints, but normal electrodiagnostic studies 
and temporary relief from corticosteroid injection?
never seldom often always 
6. Do you operate on patients with typical CTS complaints without electrodiagnostic 
confirmation?
never seldom often always 
7. Your profession is:
Neurosurgeon   Plastic surgeon    Orthopaedic surgeon   General Surgeon 
Results
Three hundred and twenty-four of 686 questionnaires were returned, which is a 
response rate of 47%. We chose to send questionnaires anonymously, with the 
regrettable consequence of not being able to send a reminder letter to increase 
the response rate. 
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Among the responders there were 62 of 110 neurosurgeons (56%), 165 of 417 
orthopaedic surgeons (40%) and 97 of 159 plastic surgeons (61%). Thirty-seven 
surgeons returned an incomplete questionnaire, because they did not operate on 
patients with CTS. Of these, 30 were orthopaedic surgeons. These questionnaires 
were not included in the analysis. 
 Thirty-one percent of neurosurgeons stated they operated 150 or more patients 
a year, or this number of patients were being operated on under their supervision. 
For orthopaedic surgeons and plastic surgeons these percentages were 7 and 15, 
respectively.
 In the whole group, 64% of surgeons stated that 96% to 100% of their patients 
with complaints suggestive of CTS underwent electrodiagnostic studies. For 
neurosurgeons, orthopaedic surgeons and plastic surgeons, these percentages 
were 90%, 68% and 39%, respectively. One surgeon did not answer this question.
Fifty-seven percent of all surgeons seldom, or never, operated on patients with 
clinically definite CTS, normal electrodiagnostic studies and failing conservative 
treatment. For neurosurgeons, orthopaedic surgeons and plastic surgeons these 
percentages were 61%, 81% and 14%, respectively. All surgeons answered this 
question. 
 Fifty-five percent of all surgeons seldom, or never, operated on patients with 
clinically definite CTS, normal electrodiagnostic studies and only temporary relief 
of symptoms from corticosteroid injection(s). For neurosurgeons, orthopaedic 
surgeons and plastic surgeons, these percentages were 53%, 72% and 27%, 
respectively. All surgeons answered this question.
Eighty percent of all surgeons seldom, or never, operated on patients with a clear 
history of CTS without confirmation of the diagnosis by electrodiagnostic studies. 
For neurosurgeons, orthopaedic surgeons and plastic surgeons, this percentage 
was 92%, 88% and 59%, respectively. Twenty-five surgeons (8%) did not answer 
this question. 
 A complete overview of the results is given in Table 2.
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Table 2. Results of the questionnaire. 
Neuro  
Surgeons 
%
Plastic 
Surgeons 
%
Orthopaedic 
Surgeons 
%
All  
Surgeons 
%
Rate of Response 56 (62/110) 61 (97/159) 40 (165/417) 47 (324/686)
No. of patients operated  
on/year
 ≤ 50
 51-100
 101-150
 ≥ 150
34
22
13
31
(21/62)
(14/62)
(8/62)
(19/62)
53
24
8
15
(51/97)
(23/97)
(8/97)
(15/97)
82
8
3
7
(136/165)
(13/165)
(5/165)
(11/165)
64
15
7
14
(208/324)
(50/324)
(21/324)
(45/324)
Electrodiagnostic studies 
performed (% patients)
 96-100
 91-95
 71-90
 61-70
 41-60
 21-40
 0-20
 unknown
90
4.8
1.6
1.6
1.6
0
0
0
(56/62)
(3/62)
(1/62)
(1/62)
(1/62)
(0/62)
(0/62)
(0/62)
39
22
12
7.2
7.2
7.2
5.2
0
(38/97)
(21/97)
(12/97)
(7/97)
(7/97)
(7/97)
(5/97)
(0/97)
68
9
10
2
3
2
5
1
(112/165)
(15/165)
(17/165)
(3/165)
(5/165)
(3/165)
(9/165)
(1/165)
64
12
9
3
4
3
4
0.3
(206/324)
(39/324)
(30/324)
(11/324)
(13/324)
(10/324)
(14/324)
(1/324)
Question 4
 never/seldom
 often/always
 unknown
61
39
0
(38/62)
(24/62)
(0/62)
14
86
0
(14/97)
(83/97)
(0/97)
81
19
0
(133/165)
(32/165)
(0/165)
57
43
0
(185/324)
(139/324)
(0/324)
Question 5
 never/seldom
 often/always
 unknown
53
39
8
(33/62)
(24/62)
(5/62)
27
65
8
(26/97)
(63/97)
(8/97)
72
21
7
(119/165)
(34/165)
(12/165)
55
37
8
(178/324)
(121/324)
(25/324)
Question 6
 never/seldom
 often/always
 unknown
92
6
2
(57/62)
(4/62)
(1/62)
59
41
0
(57/97)
(40/97)
(0/97)
88
12
0
(145/165)
(20/165)
(0/165)
 80
20
 0.3
(259/324)
(64/324)
(1/324)
The numbers of the questions refer to numbers in Table 1.
question 4: normal Electrodiagnostic studies, steroid negative response, 
question 5: normal Electrodiagnostic studies, steroid positive response, 
question 6: Electrodiagnostic studies not done. 
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Discussion
In the literature, opinions differ about the need for electrodiagnostic confirmation 
of CTS. In a study by Finsen and Russwurm,7 68 patients with typical CTS underwent 
open carpal tunnel release. They all underwent electrodiagnostic studies, but 
these were not assessed until the end of the study. Sixty-three of the 68 patients 
responded well to surgery, 14 of these had normal electrodiagnostic studies. These 
authors concluded that electrodiagnostic studies contributed little to the diagnosis 
in typical cases of CTS and might confound more than help.
 Other studies suggest that electrodiagnostic studies may have an important role 
in predicting the outcome of surgical decompression, disclosing other pathologies, 
particularly in atypical cases, and providing a useful baseline if patients do not 
improve after surgery.8,9 Electrodiagnostic studies can be of value in selecting 
patients for a specific treatment and in assessing efficacy of treatment. However, 
this is only reliable if there is a correlation between electrodiagnostic studies and 
outcome of treatment. Several studies addressed this issue.10,11 They found no, or 
only modest, correlation between electrodiagnostic studies and clinical outcome 
after surgery. Some patients with complete relief of symptoms after surgery still 
had abnormal electrodiagnostic studies, while others with ongoing symptoms had 
normalised results. 
 Since patients with CTS complaints are operated on by different surgical 
disciplines, it is interesting to know the opinion of these surgeons regarding this 
issue. Ebskov et al.12 found that most surgeons in Denmark use preoperative 
electrodiagnostic studies in less than 50% of cases. However, neurosurgeons in 
Denmark nearly always used electrodiagnostic studies. Duncan et al.13 reported 
that 37.9% of members of the American Society for Surgery of the Hand always 
used electrodiagnostic studies, 26.3% often used them and 33.2% sometimes 
used them. They also found that surgeons practicing in areas in which medical 
malpractice suits are common were much more likely to obtain electrodiagnostic 
studies. Storm et al.14 reported that 20% of 1567 patients undergoing carpal 
tunnel release in Washington State in 1999 did not have an electrodiagnostic 
examination before surgery. People living in rural areas seemed particularly likely 
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to have no, or inadequate, electrodiagnostic studies. Witt et al.15 pointed out that 
electrodiagnostic studies provide independent information on the evaluation of 
suspected CTS, not fully predictable from clinical variables alone. Controversy 
persists, however, about the necessity of electrodiagnostic studies.16 Recently, 
Graham et al.17 developed and validated clinical diagnostic criteria for CTS, which 
correlated well with judgements of a panel of experts on CTS. These criteria can 
be used to decide on possible treatment. Expanding access to electrodiagnostic 
studies can be a way to increase performance of electrodiagnostic studies in 
patients with CTS complaints. A retrospective analysis by Megerian et al.18 showed 
that point-of-service nerve conduction studies by family medicine, primary care 
and internal medicine physicians without specific neurophysiologic training for 
CTS was performed in accordance with evidence based testing parameters. CTS 
was identified in 53.1% of tested limbs, while the study was normal in 30.5%. This 
finding is interesting. However, prospective studies, with comparison to nerve 
conduction studies performed by specialists with specific neurophysiological 
training, are needed.
 In the Netherlands, the majority of neurosurgeons and orthopaedic surgeons 
seldom, or never, operate on patients without electrodiagnostic confirmation. 
This is in line with the advice in the Dutch consensus paper mentioned earlier.6 
This reluctance to operate is less when patients have had temporary relief of CTS 
complaints after locally injected corticosteroids, even if the electrodiagnostic 
studies were negative. In contrast, plastic surgeons are more likely to operate on 
patients, with clinically defined CTS and normal electrodiagnostic studies under the 
various circumstances described in the circulated questionnaire, although this was 
far from a universal finding among all plastic surgeons. 
 There may be local reasons for the particular views of different groups of 
surgeons in the Netherlands. In this country, plastic surgeons are particularly 
experienced in hand surgery, which may be a reason for the relatively low threshold 
in this group to performing operations in the face of clinically defined CTS without 
electrodiagnostic confirmation. Also, electromyography and nerve conduction 
studies are performed by neurologists and most Dutch clinical neurologists, 
who are a major referring source of these patients, find electrodiagnostic 
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testing in CTS desirable. However, they also perform nerve conduction studies 
directly requested by surgeons. Furthermore, one year of clinical neurology is an 
obligatory part of the clinical training of neurosurgeons in the Netherlands. This 
might be an explanation for the higher percentage of neurosurgeons performing 
CTS operations only in cases with electrodiagnostic confirmation. Orthopaedic 
surgeons seem to be most conservative regarding surgery in CTS patients with 
negative electrodiagnostic studies: this may be related to the fact that they have 
no training in neurology and clinical neurophysiology and, probably, rely on the 
expertise and advice of the neurologists. Whether a patient with clinically defined 
CTS without electrodiagnostic abnormalities undergoes surgery is likely to depend 
on the surgical discipline to which he or she is referred. Consequently, a clinical 
neurologist may in fact determine the treatment strategy in the Netherlands. This, 
in addition, may seriously affect the results presented in papers on the treatment 
of CTS as a result of referral bias. 
 Although not common practice in the Netherlands, fear of litigation can also play 
a role in deciding to follow the advice of a national guideline, possibly occurring 
more frequently among orthopaedic surgeons because of lack of neurological and 
neurophysiological background.
 This study has limitations. As most other surveys, this survey was prone 
to response bias. It is likely that there are more surgeons who do not perform 
CTS surgery among the non-responders. Because the questionnaires were sent 
anonymously, we were not able to find out possible reasons for not responding. 
For the same reason, it was impossible to send a reminder letter to increase 
response rate. We did not perform formal statistical testing of the data, because of 
the clearly visible differences between the data. 
 Over the last few years, ultrasonography of peripheral nerves has improved 
enormously19,20 and a significant number of patients with CTS have been 
reported to have an increased diameter of the median nerve in the carpal 
tunnel, ultrasonographically. In patients with clinically defined CTS and normal 
electrodiagnostic studies, the diagnostic value of ultrasonography needs to be 
defined, as this may provide a resolution to this dilemma.
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Abstract
High resolution sonography is a relatively new diagnostic technique in diagnosing 
carpal tunnel syndrome (CTS). Normal values in different studies, however, vary 
and this makes their practical use difficult. The aim of this study was to establish 
normal values for the median nerve cross-sectional area (CSA) and to investigate 
the value of measuring additional parameters.
 Ninety-eight wrists of 29 women and 25 men without signs or symptoms of 
CTS were included. Width and circumference of the wrist were measured. The 
CSA of the median nerve at the level of the pisiform bone was measured using 
ultrasonography.
 We found a significant correlation between the CSA of the median nerve at the 
wrist and wrist circumference. Measuring wrist circumference will establish the 
upper level of normal more accurately compared to predictions solely based upon 
gender. This has important implications in diagnosing CTS with ultrasonography. 
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Introduction
Over the past years, ultrasonographic evaluation of the size of the median nerve 
has been proposed as a useful diagnostic tool for carpal tunnel syndrome (CTS).1,2,3 
An increase in cross-sectional area (CSA) of the median nerve has been proposed 
as a useful alternative for or complementary to nerve conduction studies (NCS). 
The CSA at or just before the carpal tunnel inlet appeared to be the most consistent 
finding, although there is still discussion about the most appropriate level of 
measurement.4 The sensitivity and specificity ranged from 70 to 88% and 57 to 
97% respectively.5 However, because of poor standardisation of ultrasonography 
and different study conditions, the results of these studies cannot be compared 
reliably. 
 Several studies investigated the association between CTS and hand and wrist 
configuration. It has been suggested that body weight, stature and body mass index 
(BMI) are risk factors for developing CTS.6,7 Kamolz et al.8 reported that patients 
with CTS have more squarely formed wrists than those of a control group. 
 We measured various biophysical parameters and investigated whether a 
possible correlation with CSA could be found, in order to establish the upper limit 
of normal more accurately. Besides height and weight of subjects, we measured 
circumference of the wrist. We hypothesized that wrist circumference is associated 
with CSA of the median nerve and that normal values of CSA depend on the wrist 
circumference of a given patient. 
Materials and methods
The study was approved by the regional medical ethics committee. 
Study group
Fifty-four healthy control subjects existing of hospital personnel without signs or 
symptoms of CTS were recruited in a period of 2 months. This group consisted of 29 
women and 25 men with a mean age of 41 years (range 18 to 65 years). Weight and 
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height of each subject was noted, and BMI was calculated. We measured the wrist 
circumference at the distal wrist crease by a marking gauge and a measuring tape 
with a precision of 1 mm, both at the distal wrist crease. Sonographic examination 
was performed on both wrists. We found nine bifid median nerves, which were 
excluded from analysis. Eventually, 98 wrists were included for analysis, 52 right 
(R) and 46 left (L) ones. Right and left wrists were analysed separately. Forty-seven 
subjects were right-handed.
Ultrasonographic examination
Ultrasonographic measurements were performed by a well-trained electrodiagnostic 
technician (T.O.) from the department of Clinical Neurophysiology with sufficient 
experience in ultrasonographic assessment of nerves. A Philips Diagnostic 
Ultrasound System (model iU22) with a 5-17 MHz linear array transducer was used. 
Patients were examined sitting in an upright position with their hands resting on 
an examination couch. All wrists were examined in the neutral position with palm 
up and fingers semi-extended. The median nerve was visualised in longitudinal and 
transverse planes to confirm identification of the nerve. 
 The CSA of the median nerve was measured at the inlet of the carpal tunnel. 
The latter is defined as the proximal margin of the flexor retinaculum between 
the scaphoid tubercle and the pisiform bone. The distal wrist crease was used 
as an external landmark and subsequently, internal landmarks were used during 
scanning. We applied two different methods, one according to Duncan et al.,9 
namely the indirect ellipse method (EM) and the direct tracing method (TM). The 
inner margin of the hyper echoic sheath was considered as the margin of the nerve. 
One measurement was performed at each side. 
 Interexaminer variation was measured in 20 participants and showed differences 
in CSA of 0.61 mm2 (SD 1.48) and 0.71 mm2 (SD 1.61) for R and L, respectively.
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Results
I Descriptive statistics
Detailed clinical features of the control subjects are listed in Table 1. The CSA values 
showed pseudo normal distributions, i.e., they passed a normality test (P > 0.10). 
The mean CSA of the right median nerve for women (n = 27) was 8.4 mm2 (SD 1.4) 
and for men (n = 25) 10.2 mm2 (SD 1.8). The left median nerve CSA for women 
(n = 23) was 8.0 mm2 ( SD 1.9) and for men (n = 23) 10.0 mm2 (SD 1.9). Unpaired 
t-tests disclosed significant differences in CSA between men and women. There 
were no significant differences found between R and L for any of the parameters 
tested for males and females (P > 0.05, unpaired t test). The 95th percentile as 
upper limit of normal was estimated from exact relative frequency distributions 
with probit analysis, which were separately established for right and left (data not 
shown). As there were no significant R/L differences found, the same value can 
be used for both sides: the upper limit of normal for CSA of the median nerve at 
the wrist was 11.0 and 13.0 mm2 for women and men respectively. A minority of 
the subjects (N = 7) showed left dominance. A separate analysis between left and 
right dominant as well as left and right non-dominant hand would therefore not be 
very useful. We did perform regression analyses similar to those illustrated by Fig. 
1 and could not find any significant difference in CSA between dominant en non-
dominant sides.
Table 1. Clinical features of study group
Variable Controls 
n 54
Male/female 25/29
Mean age (y) 41 (18-65)
Left/right 46/52
Mean length (cm) 175 (153-193)
Mean weight (kg) 77 (55-115)
Mean BMI 25 (18-35)
Mean circumference wrist R/L (cm) 16.6/16.6 (13-20/13-20)
Dominant hand R 46/L 8
Mean values and (between brackets) range
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II Correlation between parameters
In pair-wise comparisons (cross-tables), we evaluated the correlation between age, 
gender, height, weight, BMI on the one hand and the median nerve CSA at the 
wrist on the other. Table 2 outlines some of the significant (S) and non-significant 
(ns) findings. The CSA of the median nerve at the wrist (R, L) generally correlated 
significantly with age, gender, height and weight, but usually not with the BMI. 
Particularly useful correlations were identified between wrist circumference (R, L) 
and CSA measurements of the median nerve at the wrist (R, L). Plots of the CSA 
parameters pertaining to the median nerve at the wrist are included in Figure 1 
showing the significant regression of median nerve CSA, obtained with the direct 
TM or the indirect EM, on wrist circumference. The correlation coefficient (Pearson 
r) was 0.6-0.7 (P < 0.0001), the proportion of variance explained by regression (r2) 
was 0.37-0.55, and the residual SD was about 1.4 mm2. For each separate plot, 
it was tested whether the regression lines pertaining to both genders could or 
could not be pooled. As there were no significant differences found between the 
corresponding slopes and intercepts, all lines were pooled; Figure 1 shows the 
regression line (continuous line) for the pooled data for men (dots) and women 
(open circles). Figure 1 also includes dotted (hyperbolic) lines to indicate the P95 
(the 95th prediction interval) of the regression line, the upper dotted line can 
barely be discerned as it has been superimposed by a separate (dashed bold line) 
regression line, which has been especially fitted to this hyperbolic line. The latter 
line represents the upper limit of normal (linear approximation precise within 
0.1 mm2 ), which can be easily found for individuals by measuring the circumference 
(X) at the wrist, then calculating the mean prediction value for the CSA of the 
median nerve using the regression equation (indicated in each panel of Figure 1) 
and adding the 95% prediction interval, which is indicated (in bold) in the upper 
right corner of each panel. The result of this calculation is covered by the equation 
listed in Table 3, together with the equations pertaining to any of the relevant 
conditions, i.e., the (R, L) side of the body and the method used for measuring the 
CSA (EM or TM). 
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Table 2. Correlation between various parameters
Variable Age Gender Height Weight BMI
Age 1
Gender S 1
Height S S 1
Weight S S S 1
BMI ns S ns S 1
CSA median right (TM) S S S S ns
CSA median right (EM) ns S S S ns
CSA median left (TM) S S S S S
CSA median left (EM) S S S S S
BMI, body mass index; CSA, cross-sectional area; EM, indirect ellipse method; ns, Pearson r not significant; 
S, Pearson r significant (p < 0.05); TM, direct tracing method.
Table 3. Equations for upper normal limit of CSA of median nerve at the wrist (mm2) 
derived from approximated upper 95% prediction limit for regression of CSA (Y variable) 
on (X variable) wrist circumference (cm).
R (TM) L (TM) R (EM) L (EM)
Y = 0.86X-2.1 Y = 1.06X-5.4 Y = 0.76X-1.6 Y = 1.02X-5.1
CSA, cross-sectional area; R, right; L, left; TM, direct tracing method; EM, indirect ellipse method.
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Figure 1. Linear regression of the CSA of the median nerve at the carpal tunnel inlet on 
wrist circumference at the distal wrist crease (see legend).
Linear regression of the CSA of the median nerve at the carpal tunnel inlet on wrist circumference at 
the distal wrist crease; Circles: women; Dots: men; Continuous line: regression line equation; Dotted 
line(s):95% prediction lines; Dashed bold line: upper limit of normal for varying wrist circumference 
(equations in Table 3).
The regression line equation is included in the bottom right corner of each panel, the correction value is 
indicated in bold in the top right corner; it can be used to find the upper normal limit for Y at a given X 
value by adding this number to the Y value predicted by regression; EM, (indirect) ellipse method; L, left; 
R, right; TM, (direct) tracing method
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Discussion
Over the past few years, several studies have been published about the use of 
sonography in CTS. It has become clear that CTS can be diagnosed quite accurately 
using this method. The most important and consistent finding has been an 
increase of the CSA of the median nerve at the tunnel inlet.3 Other applied criteria 
are the swelling ratio of the nerve, palmar bowing of the flexor retinaculum and 
measurements in the distal carpal tunnel. These measurements, however, proved 
to be less consistent. A review by Beekman et al.5 showed that critical values of 
CSA varied from 9 to 15 mm². In more recent studies,4 values varied from 9 to 
11 mm², with sensitivities ranging from 54 to 97.9% and specificities from 47 to 
100%. Variations in sample size, criteria for NCS and study design contributed to 
the variation in these data. In most studies, men and women were not analysed 
separately, probably because CTS is much more common in women than in men. 
This variation limits the use of sonography in daily clinical practice. This was also 
stated in a recent review by Seror.10 Our upper limit of normal seems high in 
comparison with findings in literature. Almost 50% of our control group were men, 
where most control groups in other studies consist of more women then men. All 
were Caucasian, which could play a role, although there is no pre-existing data 
supporting this. High frequency sonography is very suitable for superficial structures 
such as median nerve at the wrist and provides better resolution compared to 
lower frequency transducers. We used a 17 MHz linear array transducer, compared 
to 5 to 12 MHz in most other studies. This makes a very precise circumscription of 
the nerve possible when measuring CSA. This also shows that establishing normal 
values with a given ultrasound system is important and can be reliable. We tried to 
find additional parameters that could increase diagnostic accuracy of sonographic 
measurement in suspected CTS. 
 Wrist dimensions and CTS have been correlated before.6,7,11 Kamolz et al.8 and 
Moghtaderi6 showed that a more squarely formed wrist is associated with CTS. 
In the study by Moghtaderi, higher wrist circumference was not associated with 
the presence of CTS, in contrast to, among others, BMI. Boz et al.12 showed that 
hand and wrist anthropometrics are independent risk factors for CTS in females, 
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but not in males. Nakamichi and Tachibana13 showed that women with CTS had 
disproportionately smaller hands compared to a control group.
 For practical purposes, we focused on the strong correlation between the 
sonographic parameters and the circumference of the wrist at the distal wrist 
crease. Wrist circumference can thus be used to establish the upper limit of normal 
more accurately (Table 3). For example, for a patient with a circumference of the 
R wrist of 16 cm (male or female), the upper limit for the R median nerve CSA (top 
left panel) is Y = 0.86(16) - 2.1 = 11.7 mm2. Higher values may raise a suspicion of 
CTS. The present example also clearly shows how taking wrist size into account 
refines testing: for a female patient, CSA > 11.7 mm2 would have been too high for a 
wrist circumference of 16 cm, as shown in the example, and also too high according 
to the general 95th percentile for women (11.0 mm2). Likewise, for a male patient 
with a wrist circumference of 16 cm, CSA > 11.7 mm2 would have been too high 
as well, however, according to the general 95th percentile for men (13 mm2), this 
would not have raised any suspicion (Figure 1).
 An interesting finding in our study group was the presence of a bifid aspect of 
the median nerve in a relatively high percentage (8%), compared to prevalences 
in previous studies of 1.0-3.3%.14,15,16 This will be subject of a future study we are 
planning.
 Several authors mentioned that sonographic measurements have good 
intra- and interobserver agreement.17,18,19 In our study, this was confirmed for 
measurement of CSA of the median nerve at the wrist. 
 Possible limitations of our study are the small size of the control group with a 
relative homogenous population, the lack of patients with CTS and the possible 
presence of mild distal slowing of the median nerve because of the lack of 
electrodiagnostic studies. The upper limit of BMI in our study was 35; therefore 
these data may not be applicable to grossly obese patients. We also focused on 
wrist circumference and did not measure other anthropometric data like wrist-
index. Further studies are needed to investigate the true value of measuring wrist 
circumference in diagnosing CTS. 
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To conclude, normal values for the CSA can be best established by taking wrist 
circumference into account which can have important implications for diagnosing 
CTS. Using only median nerve CSA at the wrist will create larger numbers of 
false-positive and false-negative diagnoses, which can be reduced by taking wrist 
circumference into account. 
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Abstract
The aims of this study were to compare electrodiagnostic (EDX) confirmation of 
clinical diagnosis of carpal tunnel syndrome (CTS) with ultrasonography (US), using 
a new set of normal values taking wrist circumference of subjects into account 
and to determine whether EDX examination can be replaced by US to confirm CTS. 
A prospective cohort of 156 patients with idiopathic CTS underwent US and EDX 
studies. Upper levels of normal cross-sectional area of the median nerve were 
established by taking wrist circumference into account and using linear regression 
equations. Of the selected patients, 83.3% met the EDX criteria for CTS. The findings 
from the US were normal in 67 (42.9%) of 156 patients, and within this group, the 
findings from the EDX were abnormal in 44 patients (65.7%). Of 89 patients with 
abnormal findings from US, only 3 patients had normal findings from the EDX. 
 US cannot replace EDX for confirmation of clinical diagnosis of CTS. However, 
an abnormal US test result has a high positive predictive value for abnormal 
EDX in clinically defined CTS. US might reveal relevant anatomic information 
preoperatively that rarely has a direct influence on treatment management of 
patients with CTS. US testing, taking morphometric data into account, does not 
have the same diagnostic value as EDX does in confirming CTS.
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Introduction
Carpal tunnel syndrome (CTS) is a common entrapment neuropathy for which 
an adequate therapy is available. Many clinicians agree that CTS can be reliably 
diagnosed on clinical criteria only. A minority of surgeons have stated that surgical 
treatment can be performed without electrodiagnostic (EDX) confirmation.1,2,3 
However, most surgeons advocate preoperative confirmation by EDX studies 
before operating on patients with CTS to (1) confirm the diagnosis, (2) document 
the severity of median nerve pathology, and (3) to provide a baseline examination.4 
On the basis of previously reported sensitivity and specificity, nerve conduction 
tests have, until now, been used in most cases for this purpose.5 However, during 
the past few years, ultrasonographic (US) confirmation of CTS diagnosis has been 
the subject of many studies for several reasons. US has been proven to be an easily 
applicable, patient-friendly, low-cost test. Importantly, anatomic insight in the 
carpal tunnel will become available preoperatively.6 
 Earlier, we developed new US criteria that take wrist circumference into 
account, which can predict upper levels of normal more accurately, compared with 
predictions solely based on sex.7 A prospective study was conducted using these 
new US criteria to answer the following questions: (1) Can US safely replace the 
presently applied and accepted EDX confirmation of the clinical diagnosis of CTS? 
And (2) If not so, would it be justified to perform EDX in cases with normal US test 
results only? 
Materials and methods
Patients and Controls
In a prospective study, 156 patients with clinically defined CTS were carefully 
selected from consecutive patients who were suspected to have CTS and had 
been referred to our outpatient clinic by their general practitioner. The study was 
approved by the regional medical ethics committee. Written informed consent 
was obtained from each patient prior to inclusion. Clinical diagnosis of CTS was 
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used as a criterion standard. The selected patients fulfilled the following criteria: 
paresthesias or pain restricted to the median nerve innervated area (involvement 
of the fifth finger was an exclusion criterion) with two or more of the following 
major criteria: (1) paresthesias or pain awakening the patient from sleep, (2) 
positive Flick sign (paresthesias relieved by shaking the hand or holding it in a 
dependent position, (3) aggravation by activities such as driving, holding a book 
or a telephone. These criteria were adopted from Witt et al.,8 with a modification 
concerning the location of the complaints. Witt et al.8 also included patients with 
paresthesias in a glove distribution or a median and ulnar nerve distribution. When 
both hands were affected, the hand with the most severe complaints was included. 
Exclusion criteria were younger than 18 yrs; significant language barrier; mental 
disorder; clinical signs of polyneuropathy; a history of wrist trauma or surgery; 
pregnancy; severe thenar atrophy; alcoholism; arthritis or arthrosis of the wrist; 
known diabetes mellitus; rheumatoid arthritis or thyroid dysfunction; hereditary 
neuropathy with liability to pressure palsies; and other known causes of the 
complaints, that is, cervical radiculopathy and brachial plexopathy. Examiners were 
blinded to the outcome of EDX and US studies. The control group consisted of 54 
healthy volunteers without signs or symptoms of CTS. This group consisted of 29 
women and 25 men with a mean age of 41 yrs (range, 18-65) and a mean body 
mass index of 25 (18-35). All subjects underwent sonographic examination of both 
wrists; the right and left wrists were analyzed separately.7 
Clinical Testing
All patients underwent a neurologic examination, including the Tinel and Phalen 
test, sensory examination with monofilament (10g) and two-point discrimination, 
motor function of hand muscles according to the Medical Research Council, and 
grip strength with Martin Vigorimeter. Thenar atrophy was classified as absent, 
mild, or severe. Patients with severe thenar atrophy were excluded from this study. 
Electrodiagnostic Testing
All patients were tested electrodiagnostically by generally accepted standardized 
techniques according to American Association of Neuromuscular and Electro-
diagnostic Medicine (AANEM) summary statement5 and by an experienced 
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neurophysiologist who was blinded for the clinical and US measurements. US 
and EDX studies were performed on the same day for each subject. All tests were 
performed with a Viking myograph type IV (Nicolet Biomedical, Madison, WI). We 
applied our laboratory’s reference values, which had previously been obtained 
by means of the same procedure as applied in the present study. In summary, in 
all patients, skin temperature was maintained at 31˚C or higher during the test 
procedure. Skin temperature was measured at the recording site using an infrared 
thermometer (62 Mini IR thermometer, Fluke Biomedical, Cleveland, OH) before 
and after performing the tests to be sure that it was appropriate in all patients. In 
all sensory nerve conduction studies, ring electrodes were applied for recording 
sensory nerve action potentials (SNAPs). Stimulus current was adjusted to obtain 
supramaximal stimulusconditions. The optimal stimulation site was carefully 
determined to obtain a maximal SNAP amplitude under supramaximal conditions 
with a minimal stimulus strength. Signal averaging was applied on all SNAPs. In all 
tests, the onset latency was measured at the initial negative deflection of the SNAP. 
In each individual, three different kinds of sensory nerve conduction studies and 
one motor nerve conduction study were performed, which are as follows: 
1. Comparative median and ulnar sensory studies were recorded from the ring 
finger. A difference in onset latency of more than 0.4 milliseconds or absence of 
median SNAP is considered to be consistent with CTS.
2. Comparative median and radial sensory studies were recorded from the thumb. 
A difference in onset latency of more than 0.6 milliseconds or absence of 
median nerve SNAP is considered to be consistent with CTS.
3. Sensory nerve conduction studies between the digit-to-palm segment and the 
wrist-to-palm segment were recorded from digits 2 and 3 after stimulation of the 
palm as well as the wrist and elbow, respectively. Differences in sensory nerve 
conduction velocities between the digit-to-palm segment and the wrist-to-palm 
segment were subsequently calculated. Absence of SNAPs or a difference in 
conduction velocity between the palm-to-digit segment and the palm-to-wrist 
segment greater than 10 m/sec is considered to be consistent with CTS.
4. Median motor distal latency was recorded from the thenar eminence. A distal 
motor latency of more than 4.0 milliseconds (conduction distance of 60 mm) is 
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considered to be consistent with CTS. For an EDX result to be consistent with 
CTS, at least two tests had to have abnormal findings. 
Sonography
US measurements were performed according to generally accepted methodology 
by a well-trained electrodiagnostic technician (T.C.) from the department of clinical 
neurophysiology experienced in US assessment of nerves.9 The technician was 
blinded for clinical and other neurophysiologic studies. The studies were performed 
with a 5-17 MHz linear array transducer of a Philips Diagnostic Ultrasound System 
(model iU22). The patients were examined while sitting in a chair with their hands 
resting on an examination couch. All wrists were examined in the neutral position 
with the palm up and the fingers semi-extended. The median nerve was visualized in 
longitudinal and transverse planes to confirm identification of the nerve. The cross-
sectional area (CSA) of the median nerve was measured at the inlet of the carpal 
tunnel, which is defined as the proximal margin of the flexor retinaculum between 
the scaphoid tubercle and the pisiform bone. The distal wrist crease was used 
as an external landmark, and, subsequently, during scanning, internal landmarks 
were used. CSA was measured by means of a direct tracing method using the inner 
margin of the hyperechoic sheath as the margin of the nerve. If a bifid median nerve 
was found, CSA of both branches were added. Wrist circumference was measured 
at the distal wrist crease by a marking gauge and a measuring tape with a precision 
of 1 mm. Fifty-four healthy subjects also underwent US studies. Previously we 
collected reference values for EDX studies and for US in our laboratory.7 
Statistical Analysis
Data concerning clinical variables, nerve conduction studies, and US were 
processed using Microsoft Office Excel and Access, and all statistical analyses were 
performed using the Statistical Package for the Social Sciences Statistics 17.0. 
Comparison between the patients and controls, and the patients with normal and 
abnormal EDX and US results was performed with a t test for continuous variables 
or a χ2 test for categorical variables, as appropriate. P values of less than 0.05 
were considered statistically significant. Reference values for quantitative US were 
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obtained in the group of controls using regression equations based on the left/
right side and circumference of the wrist. Z score was used to determine whether 
the observed CSA differed from the mean of normal. A Z score of less than 2, by 
definition, would be a normal result. The following regression equations were 
used: Zright = (measured CSA – 0.86*wrist circumference)/1.45 for the right side 
and Z
left 
= (measured CSA – 1.06*wrist circumference)/1.55 for the left. For more 
extensive data, we refer to the previous publication.7
Results
Within the group of 156 patients with clinically defined CTS, 130 patients (83.3%) 
met the EDX criteria of CTS and 26 (16.7%) did not (Table 1). The latter turned 
out to be significantly younger (P < 0.01), were relatively more often women 
(P < 0.05), and showed shorter mean ± SD duration of symptoms (18.2 ± 23.2 and 
34.0 ± 53.7 months, respectively, P = 0.012). In contrast, there were significantly 
more patients with mild thenar atrophy and weakness in the group with abnormal 
EDX results (P < 0.01; Table 2). In contrast to EDX, 89 patients (57.1%) had abnormal 
US results (Table 1). Between the groups of patients with normal or abnormal US 
results, statistically significant differences were not found with respect to mean 
or median duration of symptoms, sex, age, body mass index, abnormal two-
point discrimination or the occurrence of mild thenar atrophy or weakness of the 
abductor pollicis brevis (APB) muscle (Table 3). 
Table 1. Ultrasonographic and electrodiagnostic test results in 156 patients with clinically 
defined CTS
Abnormal EDX Normal EDX Total
Abnormal US 86 [4] 3 [0] 89 (57.1%)
Normal US 44 [6] 23 [2] 67 (42.9%)
Total 130 (83.3%) 26 (16.7%) 156
Chi-square < 0.001; Between square brackets: bifid median nerve 
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Table 2. Clinical characteristics split by EDX test results
EDX result Normal 
(n = 26)
Abnormal
(n = 130) 
P Total
 (N = 156)
Controls
(N = 54)
Age, yrs 40.4 ± 10.6 50.7 ± 13.5 < 0.01 48.9 ± 13.6 41 (18-65)
Duration of symptoms, mos 18.2 ± 23.2 34.0 ± 53.7 0.088
Sex (female) 25 (96.2%) 96 (73.8%) 0.013 121 (77.6%) 29 (54%)
R wrist included 13 (50.0%) 72  (55.4%) 0.615 85 (54.5%) 46 L/52 R
BMI 26.9 ± 4.6 27.7 ± 5.1 0.301 27.6 ± 5.0 25 (18-35)
M. APB atrophy 1  (3.8%) 35 (26.9%) 0.009 36 (23.1%)
Weakness m. APB 2  (7.7%) 44 (33.8%) 0.007 46 (29.5%)
Weakness m. opponens 1  (3.8%) 9  (6.9%) 0.548 10  (6.4%)
Sensory loss 22 (84.6%) 97 (74.6%) 0.299 119 (76.2%)
Two-point discrimination 18 (69.2%) 81 (62.3%) 0.533 99 (63.4%)
Monofilament 11 (42.3%) 54 (41.5%) 0.991 65 (41.7%)
Values are presented as mean ± standard deviation, mean (range), of number (percentage). Sensory loss 
is defined as numbness reported by the patient at the neurologic examination by means of two-point 
discrimination and/or monofilament. BMI indicates body mass index,; L, left; m, musculus; R, right.   
Sixty-seven (42.9%) of 156 patients had normal US results and, within this group, 
44 patients (65.7%) had abnormal EDX results (Table 1). In the group with normal 
EDX results, there were significantly more female patients; less often, they had 
weakness of the musculus APB (Table 3). In the whole group of patients with 
clinical CTS, three patients (1.9%) had normal EDX and abnormal US results, 
one patient had one abnormal finding from the EDX, whereas the others had no 
abnormal findings from the EDX, and all three patients had a normal neurologic 
examination except sensory loss in two patients (Table 3). The results of the US 
in these three patients were unmistakable and showed Z scores of 2.50, 2.63 and 
3.19. The relationship between CSA in US and EDX is shown in Figure 1. The boxplot 
shows the spread of the mean CSA and 95% confidence intervals not corrected for 
wrist circumference. Twelve patients (7.7%) had a bifid median nerve on US studies 
(Table 1). Four of them (33.3%) had abnormal total CSA when the two branches of 
the bifid median nerve were added. A persistent median artery was never seen. 
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Figure 1. Correlation between CSA of the median nerve at the inlet of the carpal tunnel 
and EDX. CI indicates confidence interval
Discussion
Clinical data obtained by carefully taken history and physical examination are very 
powerful for the diagnosis of CTS. Generally, in clinical practice in the Netherlands, 
surgeons want additional preoperative tests to confirm the clinical diagnosis.4 In 
the literature,6,10 sensitivity and specificity of US in confirming CTS show a wide 
variation: sensitivity of increase in CSA at the inlet of the carpal tunnel varies from 
44% to 95% and specificity from 57% to 100%.10 In a meta-analysis, Fowler et al.11 
found a composite sensitivity and specificity of US of 77.6% (95% confidence interval, 
71.6%-83.6%) and 86.8% (95% confidence interval, 78.9%-94.8%), respectively. 
Small sample size of study group or controls, different clinical and EDX criteria for 
CTS, and variability in cutoff values for CSA may be the reasons for this variety.10,11 
In comparison with these studies, the sensitivity of US for CTS in the present study 
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is relatively low. An explanation may be the use of a new diagnostic parameter in US 
that calculates cutoff points taking wrist circumference into account and possibly 
spectrum bias. Recently, Roll et al.12 concluded that a true meta-analysis was 
not possible because of significant methodological discrepancies among studies. 
They state that anthropometry can be an important factor to consider and that 
variability in CSA also exists in subjects without complaints of CTS. It was previously 
found that wrist circumference is relevant for CSA and that it is also related to 
body length.7 With this in mind, one can hypothesize that, in other studies, taller 
patients were more easily diagnosed as having CTS and that shorter patients were, 
by error, not diagnosed. Visser et al.9 used clinical diagnosis of CTS as a criterion 
standard, as was done in the present study: the diagnostic values of EDX and US 
are comparable and US had additional value in the cases with normal findings from 
EDX. Fifty-seven percent of patients with normal EDX, had abnormal findings from 
US in the study by Visser et al.9 In the present study, this was 12.5%. The reason 
for this difference might be, for example, that there were more small people with 
smaller wrists in their control group than in their patient group. In that case, the 
mean value for normal CSA is lower compared with taking wrist circumference into 
account, as we did.
 Various authors suggested using US as a screening tool in patients suspected 
of having CTS.9,13 Pastare et al.13 showed that EDX showed greater diagnostic 
sensitivity (82%) than did US (62%) in supporting a diagnosis of CTS. Pastare et al.13 
suggested that an abnormal US test result could eliminate the need for EDX studies 
in more than 50% of patients with a highly likely clinical diagnosis of CTS and in 
nearly 30% of patients with an intermediate diagnosis of CTS. In their study,13 
the positive predictive value of US for CTS according to EDX studies was 100%. 
In the present study, the chance of a normal EDX result in case of an abnormal 
US test result is rather small (3 out of 89 patients, 3.3%). In those cases, one may 
therefore probably safely apply US as a test for confirmation of clinically defined 
CTS. In 89 (57%) out of 156 patients from this group, the clinical diagnosis could 
be confirmed by US alone. Because the sensitivity is relatively low (57%), using US 
as a screening tool is not recommended. In the present study, false-negative EDX 
was more present in young women with a short duration of symptoms. A possible 
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explanation may be that, in patients with shorter duration of symptoms, nerve 
damage is not present yet and EDX remains negative as a consequence. Because of 
more knowledge of the syndrome and its symptoms, it is also possible that patients 
visit their general practitioner earlier or are being referred for examination more 
easily.
 US has the advantage over EDX of giving relevant anatomic information on 
the content of the carpal tunnel. For example, 12 bifid median nerves were found 
among the study group. EDX, however, can evaluate the severity of CTS through 
the quantification of sensory axonal loss, can exclude other nerve abnormalities, 
and can provide a baseline examination preoperatively. This study has certain 
limitations. The control group was not completely matched for age and sex with 
the study group, and this could be of influence because these factors are correlated 
to the development of CTS. Only patients who met specific clinical criteria for 
definite idiopathic CTS were included to study a group of subjects as uniformly 
as possible. This limits the use of the results in daily clinical practice to patients 
with CTS who complain of paresthesias not exceeding median nerve innervated 
area. Therefore, these findings have to be confirmed in patients with CTS with 
complaints also outside the median nerve. Because clinical diagnosis was used as 
a criterion standard and all included patients had clinical CTS, specificity could not 
be calculated. Patients with severe atrophy were excluded because we wanted to 
study a homogeneous population. We do not think that this is very relevant because 
Kasius et al.14 mentioned abnormal US results in 79% of patients with severe CTS. 
This suggests that the sensitivity of US and EDX might be higher if all CTS cases were 
included. Patients with bifid median nerve were included, and CSA was calculated 
by adding the two separate branches. There is no validated method to measure 
CSA of a bifid median nerve, but adding the two branches has been used before.15 
However, after calculating the values without the bifid cases, the results showed 
only slight differences. Without bifid median nerve values, sensitivity would have 
been slightly higher than with these values, so the method of added areas might 
lead to an underestimation of the sensitivity of US in the present study. Because 
it was suggested that CTS in patients with an extramedian sensory distribution (so 
including digit 5) was less severe on EDX,16 it would be interesting to study that 
group also to compare the US results. 
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The reason why EDX is more sensitive in confirming the clinical diagnosis of CTS 
than US is not clear. Maybe we have to conclude that US techniques are not yet 
as far developed to measure small changes in morphology of the median nerve 
in CTS. Clinical diagnosis was used as a criterion standard, because there is no 
other generally accepted criterion standard. If clinical definition is accepted as the 
criterion standard, which is in fact often the case, then confirmation with EDX or US 
is obviously rather pointless. The advantages of applying a criterion standard based 
solely on clinical criteria is that patients will not be deprived from therapeutic 
intervention if test results are false negative. Moreover, if intervention is indicated, 
there is no delay caused by additional tests. However, before surgical intervention, 
a form of objective confirmation is often preferred by surgeons, especially when 
there are only signs and symptoms, as is often the case in CTS. In addition, legal 
implications may be involved. Therefore, a high correlation between clinical 
diagnosis and objective measures is desired. 
 In conclusion, according to the present study, US, taking wrist circumference 
into account, cannot replace EDX for the confirmation of the clinical diagnosis of 
CTS because US misses one of three cases diagnosed by EDX, whereas US confirms 
CTS in 2% of cases (3 of 156) with normal EDX results. However, an abnormal 
US test result has a high positive predictive value for an abnormal EDX result in 
clinically defined CTS. 
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Abstract
Patients with complaints of carpal tunnel syndrome (CTS) with signs and symptoms 
not exclusively confined to the median nerve territory, but otherwise fulfilling the 
clinical criteria may erroneously be withheld from therapy. One hundred and twenty 
one patients who fulfilled the clinical criteria for the diagnosis of CTS with signs 
and symptoms restricted to the median nerve territory (group A) and 91 patients 
without this restriction (group B) were included in a prospective cohort study. All 
patients fulfilled electrodiagnostic criteria of CTS. Outcome was determined after 7 
to 9 months by means of Symptom Severity Score (SSS) and Functional Status Score 
(FSS) according to Levine and a patient satisfaction questionnaire. Response rates 
were 81.8% (group A) and 82.4% (group B). All patients in group B had sensory 
symptoms involving digit 5. There were no significant differences in improvement 
of SSS, FSS and patient satisfaction scores between groups after treatment. CTS 
patients with characteristic sensory signs and symptoms not exclusively restricted 
to the median nerve innervated area should be treated in the same manner as 
patients with CTS symptoms restricted to the median nerve innervated area and 
should therefore not be withheld from surgical treatment. 
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Introduction
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy.1,2 
Diagnosis is based on clinical signs and symptoms that typically show existence of 
nocturnal acroparesthesia in the area innervated by the median nerve. If CTS signs 
and symptoms are typical, these may easily and reliably lead to a definite diagnosis 
on clinical grounds exclusively. However, it is well known that a substantial number 
of CTS patients report signs and symptoms in the whole hand, which may eventually 
lead to uncertainty of the diagnosis of CTS. This may discourage the performance 
of an operative decompression of the median nerve or other types of intervention. 
Contrary to most other surgeons in the Netherlands, some surgeons do not require 
electrodiagnostic confirmation prior to operation in the case of a definite clinical 
diagnosis of CTS.3,4 However, in patients with complaints outside the anatomical 
median nerve territory, hesitation may arise even if they fulfill electrodiagnostic 
criteria for CTS. As a consequence, this may exclude patients from proven effective 
operative therapy. The present study was conducted to determine whether 
CTS patients with signs and symptoms not solely confined to the median nerve 
innervated area, which in addition were electrodiagnostically confirmed, benefit 
from treatment to the same extent as patients who do fit classic clinical CTS criteria. 
Materials and methods
Patients 
In this prospective cohort study, patients with complaints suggestive of CTS 
were referred to our outpatient clinic by their general practitioner. Patients were 
included if they fulfilled clinical criteria for CTS as well as electrodiagnostic criteria. 
Patients were divided into two groups according to strict clinical criteria having 
a typical, ‘classic’ CTS (group A, CCTS) or less typical, ‘non-classic’ CTS (group B, 
NCTS). Criteria were adapted from Witt et al., who distinguished patients with 
‘definite’ and ‘possible’ CTS.5 Patients with paresthesia and/or pain in median 
nerve innervated area and 2 or more major criteria (Table 1) were defined as having 
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classic CTS. Patients with paresthesia and/or pain in median nerve innervated area 
and the fifth finger and 1 major or 2 minor criteria were categorized as non-classic 
CTS. Involvement of the fifth finger was indicated by history and confirmed in the 
Katz diagram.6 Patients with sensory symptoms outside the classic median nerve 
innervated area were thus classified as ‘non-classic’ CTS patients. When both 
hands were affected, the hand with the most severe complaints was included. 
Other exclusion criteria were age under 18, a significant language barrier, mental 
disorder, clinical signs of polyneuropathy, a history of wrist trauma or surgery, 
pregnancy, severe thenar atrophy, alcoholism, arthritis or arthrosis of the wrist, 
known diabetes mellitus, rheumatoid arthritis or thyroid dysfunction, HNLPP 
(Hereditary Neuropathy with Liability to Pressure Palsies), other known causes 
of the complaints and bifid median nerve on ultrasound imaging. Patients filled 
in a Symptom Severity Score (SSS) and Functional Status Score (FSS) according to 
Levine7 before treatment and 7 (90% of the scores) or ultimately 9 months (some 
responded after a second call) after treatment. This is a validated patient-reported 
outcome measure for studies involving CTS.8 Patients also received a multiple choice 
questionnaire to indicate their satisfaction with treatment result. The study was 
approved by the regional medical ethics committee. Written informed consent was 
obtained from each patient prior to inclusion. Electrodiagnostic reference values 
were collected in the same laboratory by examining 47 asymptomatic volunteers. 
Clinical testing
All patients were clinically examined by experienced examiners. A complete 
neurological examination was performed. Tinel and Phalen sign were tested, and 
sensory examination was performed with a monofilament (10g) and two-point 
discrimination. Motor function was tested according to MRC (Medical Research 
Council) as well as grip strength with Martin vigorimeter.9 Thenar atrophy was 
classified as absent, mild or severe. Patients with severe thenar atrophy were 
excluded from this study.
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Table 1. Major and minor criteria in diagnosing CTS
Major Criteria
1) Nocturnal paresthesia
2) Positive Flick sign
3) Aggravation by driving, holding a book or telephone
Minor Criteria
1) Subjective weakness
2) Clumsiness of the hand
3) Positive Tinel or Phalen sign
Flick sign: paresthesia relieved by shaking the hand or holding it in a dependent position
Electrodiagnostic testing
All patients underwent electrodiagnostic tests performed with standardized 
techniques according to AANEM summary statement10 and by an experienced 
neurophysiologist who was blinded for clinical data. Electrodiagnostic studies 
were performed on the same day for each subject. All tests were performed 
with a Viking myograph type IV (Nicolet Biomedical, Madison, WI, USA). We used 
earlier developed reference values that were obtained in the same laboratory by 
means of the same procedure as applied in the present study. Skin temperature 
was maintained at 31°C or more during the test procedure. It was measured at 
the recording site by means of an infrared thermometer (62 Mini IR thermometer, 
Fluke Biomedical, Cleveland OH, USA) before and after performing the tests. 
Three different kinds of sensory nerve conduction studies were performed in each 
individual, as well as one motor nerve conduction study. Difference between onset 
latencies of the median nerve and ipsilateral ulnar nerve were recorded from 
the fourth finger over the same distance. Conduction velocity of the ulnar nerve 
should be at least 50 m/s. A difference in onset latency of more than 0.4 ms or the 
absence of the median sensory nerve action potential (SNAP) is considered to be 
consistent with CTS. SNAPs from median and radial nerves were recorded from the 
first finger after stimulation of the median and radial nerve at the wrist, with the 
same conduction distance. A difference in onset latency of more than 0.6 ms or 
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absence of the median SNAP is considered to be consistent with CTS. Segmental 
sensory conduction studies across the wrist recorded SNAPs from digits 2 and 3 
after stimulation of the median nerve at the palm and at the wrist. Absence of 
SNAPs or a difference in conduction velocity between the palm-to-digit and palm-
to-wrist greater than 10 m/s is considered to be consistent with CTS. Median motor 
nerve conduction studies were performed by stimulating median nerve at the wrist 
and at the cubital fossa. A distal motor latency of more than 4.0 ms is considered to 
be consistent with CTS. For an EDX result to be consistent with CTS, at least 2 tests 
had to be abnormal. 
Statistical analysis
Data concerning clinical variables and nerve conduction studies were processed 
using Microsoft Office Excell and Access and all statistical analyses were performed 
using SPSS Statistics 17.0. Comparison between patients and controls was 
performed with a t test for continuous variables or a χ2 test for categorical variables, 
as appropriate, and, in case of non-nominal distribution, the Mann-Whitney U test. 
P < 0.05 was considered to be statistically significant.
Treatment
Patients who fulfilled clinical criteria for group A or B and who had EDX corresponding 
with CTS criteria were informed about the study objectives. We discussed the 
different treatment options with patients: conservative treatment with a wrist splint 
during the night, local corticosteroid injection (methylprednisolone 40 mg) at the 
carpal tunnel or surgical decompression of the median nerve at the carpal tunnel. 
Patients were informed on treatment options according to the Dutch Consensus 
Guideline11 for diagnosis and treatment of carpal tunnel syndrome. They were 
explained that on the long-term, surgical treatment could be expected to have the 
best treatment results.11-14 Surgery was performed by experienced neurosurgeons 
under local anaesthesia with an open surgical procedure. 
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Follow-up
The neurosurgeon performed the follow-up for removal of stitches and control of 
wound healing of the surgically treated patients 1 and 4 weeks after the operation. 
Six months after treatment all patients were sent the Symptom Severity Score 
and Functional Status Score according to Levine.7 We also sent a multiple choice 
questionnaire in which patients were asked to indicate the effect of treatment 
(no complaints, rarely any, occasional complaints, often, situation unchanged or 
deterioration). For the purpose of statistical analysis, we divided these options into 
four categories: 1) full recovery, 2) partial recovery, 3) no recovery at all, and 4) 
deterioration.
Results
Patients 
Two hundred and twenty eight patients who initially met the inclusion criteria 
were selected, 131 patients with clinical ‘classic’ CTS (group A) and 97 patients with 
clinical ‘non-classic’ CTS (group B). Sixteen patients with a bifid median nerve on 
US were excluded, 10 in group A and 6 in group B. Clinical features of the patients 
are presented in Table 2. In group B, all patients presented with sensory symptoms 
or signs in median nerve sensory territory and in digit 5. There was a significantly 
higher percentage of women in the group B (72.7% vs. 86.8%, P = 0.013). No 
statistically significant differences were found in age, duration of symptoms, 
BMI, weakness or atrophy of the abductor pollicis brevis muscle, sensory loss or 
occurrence of Tinel or Phalen sign between groups. Symptom Status Score on 
inclusion was not significantly different between groups, and Functional Severity 
Score was significantly higher in group B on inclusion and follow up. This reflects 
mainly the surgically treated patients, since the conservatively treated group was 
significantly smaller than the surgically treated group. 
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Table 2. Clinical features of CTS patients 
 N*
A
N = 121 N*
B
N = 91 p
Sex female 121 88(72.7%) 91 79(86.8%) 0.013
Age (mean ± SD, years) 121 50.59 ± 13.21 91 52.20 ± 13.78 n.s
Range 121 18-86 91 23-85
Median duration of symptoms (months) 120 12.00 91 12.00
Mean duration of symptoms (months) 120 34.78 ± 55.31 91 37.68 ± 57.93 n.s.
Wrist included right 121 67(55.4%) 91 61(67.0%) n.s.
BMI 121 27.63 ± 5.08 90 27.52 ± 4.78 n.s.
Atrophy of abductor pollicis brevis muscle 116 33(28.4%) 90 27(30.0%) n.s.
Weakness 
 APB muscle 119 41(34.5%) 89 25(28.1%) n.s.
Opponens pollicis muscle 119 7(5.9%) 89 3(3.4%) n.s.
Disturbed sensibility
 Two-point discrimination 120 78(65.0%) 91 55(60.4%) n.s.
Monofilament 119 49(41.2%) 89 43(48.3%) n.s.
Phalen positive 121 91(75.2%) 91 78(85.7%) n.s.
Tinel positive 121 78(64.5%) 91 56(61.5%) n.s.
* Numbers due to missing values
A: CTS patients with clinical signs and symptoms restricted to the median nerve innervated area
B: CTS patients with signs and symptoms not restricted to the median nerve innervated area
Electrodiagnostic tests
All patients fulfilled electrodiagnostic criteria for CTS. Details are summarized 
in Table 3. Nerve conduction velocity in the palm to wrist segment in digit 3 in 
group A (P = 0.001) was significantly lower than in group B and mean onset latency 
difference in digit 1 was significantly lower in group B (1.26 vs. 1.45 ms, P = 0.036). 
Other EDX test results showed no significant differences between groups. Figure 1 
shows electrophysiologic severity according to Padua et al.15 in group A versus B 
patients. 
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Table 3. Electrodiagnostic test results in CTS patients 
N*
A
N = 121
mean±SD N*
B
N = 91
mean±SD P
Digit 4 mean latency difference (ms) 60 1.70 ± 0.78 51 1.44 ± 0.69 n.s.
Unrecordable 61 50.4% 40 44.0% n.s.
Digit 1 mean latency difference (ms) 81 1.45 ± 0.60 71 1.26 ± 0.54 0.036
Unrecordable 39 32.2% 19 20.9% n.s.
Digit 2 mean NCV dig 2-palm (m/s)
Unrecordable
98
22
47.50 ± 7.81
18.2%
78
13
48.74 ± 7.69
14.3%
n.s.
n.s.
Mean NCV palm-wrist (m/s) 90 30.36 ± 7.32 77 32.46 ± 7.68 n.s.
Digit 3 mean NCV dig 3-palm (m/s)
Unrecordable
96
24
46.29 ± 6.72
19.8%
75
16
47.21 ± 7.45
17.6%
n.s.
n.s.
Mean NCV palm-wrist (m/s) 89 29.00 ± 7.44 73 32.86 ± 7.22 0.001
DML mean (ms) 116 5.69 ± 1.79 91 5.27 ± 1.59 n.s.
Median CMAP APB unrecordable 5 4.1% 0 0 n.s.
* Number of patients may vary due to missing values or unrecordable SNAPs or CMAPs
A: CTS patients with clinical signs and symptoms restricted to the median nerve innervated area
B: CTS patients with signs and symptoms not restricted to the median nerve innervated area
SNAP: sensory nerve action potential; NCV: nerve conducton velocity; DML: distal motor latency; CMAP: 
compound muscle action potential; APB: abductor pollicis brevis muscle
Outcome
In group A, 99 out of 121 patients completed a follow-up. In group B, 80 out of 
91 patients returned questionnaires. See Tables 4A and B for results of SSS en FSS 
and Figures 2 and 3 for distribution of outcome according to patient satisfaction 
questionnaire. In the whole group SSS at follow up was significantly higher in group 
B (NCTS, P = 0.035) as compared to group A (CCTS), but the difference between 
inclusion and follow-up was not. FSS was significantly higher at inclusion and 
at follow-up in group B patients treated with surgery (P = 0.007 and P = 0.013 
respectively) compared to group A patients. No difference was seen in improvement 
of FSS between groups A and B at inclusion and at follow-up. Only a small number 
of patients were treated non-surgically. Out of all patients, 19 were treated 
conservatively and 153 were treated surgically. Of conservatively treated patients, 
83
Treatment outcome in carpal tunnel syndrome
6
only 3 received local corticosteroid injection at the carpal tunnel. Improvement 
in the non-surgically treated patients was significantly lower (P = 0.000, Mann-
Whitney U). Full recovery was reported by 60.6% of patients in group A (CCTS) after 
7 to 9 months of follow-up, vs. 48.0% in group B (NCTS, P = 0.222 Figure 2).
60,0%
40,0%
20,0%
0,0%
Minimaal Mild Moderate Severe Extreme
Electrophysiological classificaon
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NCTS
Figure 1. Group A and B versus electrophysiological severity according to Padua et al.15
CCTS: group A, CTS patients with clinical signs and symptoms restricted to the median nerve innervated 
area
NCTS: group B, CTS patients with signs and symptoms not restricted to the median nerve innervated area
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Outcome
full recovery
paral recovery
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Figure 2. Outcome all patients
CCTS: group A, CTS patients with clinical signs and symptoms restricted to the median nerve innervated 
area; N=99, 22 lost to follow up, response rate 81.8%; NCTS: group B, CTS patients with signs and symptoms 
not restricted to the median nerve innervated area; N=75, 16 lost to follow up, response rate 82.4%
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Figure 3. Outcome patients surgical treatment
CCTS: group A: CTS patients with clinical signs and symptoms restricted to the median nerve innervated 
area; N=91; NCTS: group B: CTS patients with signs and symptoms not restricted to the median nerve 
innervated area; N=64
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Table 4. Outcome SSS and FSS
Table 4A. Symptom Severity Score
 A  B
N* mean±sd N* mean±sd P
Surgery
At inclusion 89 2.87 ± 0.65 64 3.08 ± 0.71 n.s.
At follow up 89 1.50 ± 0.69 64 1.71 ± 0.77 n.s.
Difference 89 1.36 ± 0.82 64 1.37 ± 0.98 n.s.
Conservative
At inclusion  8 2.41 ± 0.80 11 2.65 ± 0.69 n.s.
At follow up  8 2.14 ± 0.83 11 2.31 ± 0.83 n.s.
Difference  8 0.28 ± 0.38 11 0.35 ± 0.93 n.s.
Total
At inclusion 97 2.83 ± 0.67 75 3.02 ± 0.72 n.s.
At follow up 97 1.55 ± 0.72 75 1.80 ± 0.80 0.035
Difference 97 1.27 ± 0.85 75 1.22 ± 1.03 n.s.
* Number of patients varies due to missing values; A: CTS patients with clinical signs and symptoms 
restricted to the median nerve innervated area; B: CTS patients with signs and symptoms not restricted to 
the median nerve innervated area
Table 4B. Functional Status Score
 A  B
N* mean±sd N* mean±sd P
Surgery
At inclusion 86 2.16 ± 0.70 61 2.48 ± 0.68 0.007
At follow up 86 1.47 ± 0.64 61 1.78 ± 0.77 0.013
Difference 86 0.68 ± 0.84 61 0.70 ± 0.93 n.s.
Conservative
At inclusion 8 2.00 ± 0.69 11 2.19 ± 0.79 n.s.
At follow up 8 1.65 ± 0.65 11 2.03 ± 0.86 n.s.
Difference 8 0.35 ± 0.41 11 0.16 ± 0.63 n.s.
Total
At inclusion 94 2.15 ± 0.70 72 2.43 ± 0.70 0.009
At follow up 94 1.49 ± 0.64 72 1.82 ± 0.79 0.005
Difference 94 0.66 ± 0.82 72 0.62 ± 0.91 n.s.
* Number of patients varies due to missing values; A: CTS patients with clinical signs and symptoms 
restricted to the median nerve innervated area; B: CTS patients with signs and symptoms not restricted to 
the median nerve innervated area
86
Chapter 6
Discussion
The diagnostic hallmarks of CTS are the symptoms reported by patients during 
history-taking, which may vary considerably. Classic symptoms of CTS typically 
include sensory symptoms in the territory of the median nerve. However, it is 
generally known among clinicians that patients often report symptoms outside 
the median nerve territory. Typical CTS complaints like nocturnal paresthesia or 
aggravation by driving or holding a telephone were often also present in group B 
in the present study. However, because of our strict clinical criteria, these patients 
were categorized as having ‘non-classic’ CTS, because of the presence of symptoms 
in digit 5. Therefore, in the present study, ‘non-classic’ CTS corresponds with CTS 
patients with sensory symptoms in median nerve distribution and digit 5. In most 
cases patients undergo EDX to confirm the diagnosis, however there is no generally 
accepted gold standard. Studies of CTS patients frequently mention symptoms 
involving ulnar nerve territory or whole hand distributions of complaints.16-18 In 
the study by Clark et al.17, sensory disturbance in the little finger was mentioned 
in 39% of patients, and 11% mentioned occurrence of pain in this finger. Stevens 
et al.16 found that in a group of 100 electrodiagnostically confirmed CTS patients, 
paresthesia of the little finger was present in 56.6% of hands. In 2.5% of hands, the 
little finger was even the most affected finger in this study. This was not the case in 
the population in the current study. Gupta et al.19 found that symptoms confined to 
the median nerve distribution only, were present in 33% of affected hands, while 
in 40% of hands, sensory symptoms were present in the whole hand. Improvement 
after therapeutic intervention may indirectly be interpreted as a confirmation of 
the clinical diagnosis. In the present study, no significant difference in outcome was 
found in patients with ‘classic’ and ‘non-classic’ sensory distribution of complaints 
after 7 to 9 months of follow-up. EDX was not significantly different between 
groups, except for 2 out of 5 tests, which showed a lower nerve conduction 
velocity across the carpal tunnel in digit 3 and higher latency difference between 
median and radial SNAPs in digit 1 in patients with ‘classic’ CTS. This suggests 
that median nerve dysfunction is more severe in patients with CTS symptoms 
restricted to the median nerve area, in accordance with Caliandro et al., who 
87
Treatment outcome in carpal tunnel syndrome
6
found that the likelihood of median nerve distribution increases with more severe 
neurophysiologic abnormalities.18 
 The mechanisms that cause extra-median spread of symptoms in CTS patients 
are not known and are subject to discussion. Some authors suggest that abnormal 
activation of cortical sensory areas beyond the median nerve area can be responsible 
for GLOVE distribution.18,20,21 Zanette et al. found that extra-median spread of 
sensory symptoms is associated with higher levels of pain and paresthesia.20 
Contrary to our results, they found significantly higher scores on SSS (numbness 
and tingling sensations) in CTS patients with a glove distribution in comparison to 
a median nerve distribution, and no significant difference in FSS between groups. 
In the present study, FSS at inclusion and at follow-up was significantly higher in 
patients with symptoms extending the median nerve innervated area. Remarkably, 
in the study by Zanette, tactile hypesthesia was significantly more present in 
patients with median nerve distribution. They hypothesized that central nervous 
system mechanisms of plasticity may be an explanation for the spread of symptoms 
in CTS. Others found that enlargement of cortical hand presentation is correlated 
with the inability of patients to correctly identify the involved hand districts.21 Not 
all patients in the present study had objective sensory loss by means of decreased 
two-point discrimination and/or monofilament testing. Some patients reporting 
sensory disturbances in digit 5 had no sensory loss in this digit on examination. 
This could reflect the result of a central process rather than a peripheral one. 
 Another possible explanation for extra-median spread of sensory symptoms is 
involvement of ulnar nerve fibers. Many studies concern ulnar nerve conduction 
in patients with CTS without finding a clear explanation for presence of minimal 
changes in ulnar nerve conduction in CTS patients.22,23 Ginanneschi found 
significant changes in ulnar nerve conduction in CTS, even in the early stages.23 
They hypothesize that damage to ulnar fibers by compression in Guyon’s canal as 
a consequence of high pressure in the carpal tunnel is the cause. In the present 
study, all patients in group B had sensory symptoms in the median nerve territory 
and digit 5. Patients with symptoms primarily in ulnar nerve territory or symptoms 
suspected for ulnaropathy were not included. This is also supported by the fact 
that no significant differences were found in outcome measures between these 
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groups. It would be interesting to know whether patients with the clinical diagnosis 
of CTS according to our criteria in group A and B benefit from operative therapy, 
regardless the outcome of electrodiagnostic test results. As in the Netherlands 
most surgeons require preoperative electrodiagnostic confirmation, we chose to 
include only CTS patients who fulfilled electrodiagnostic criteria as well. We found 
no statistically significant differences in outcome after surgical or conservative 
treatment between both patient groups. This observation means that in daily 
clinical practice, CTS patients with sensory symptoms also involving the fifth finger 
have equal chances of positive results of treatment as patients with classic median 
nerve distribution. As was expected, the majority of patients who underwent 
operative treatment had full or partial recovery of complaints. Comparison of 
surgical and non-surgical treatment of CTS was not the main subject of this study. 
Patients treated conservatively showed a significantly smaller improvement on 
follow-up than surgically treated patients, however, the group of patients that was 
treated conservatively was very small. Our study has some limitations. We included 
patients suspected to have CTS referred by their general practitioner, therefore 
selection bias cannot be excluded. However, this reflects daily clinical practice in 
the Netherlands, where patients can only visit an outpatient clinic by referral by 
their general practitioner. Patients with polyneuropathy or diabetes mellitus, more 
likely to present with atypical CTS complaints, were excluded from this study. More 
patients were treated surgically in group A than in group B. There might be a bias 
in the fact that we made a distinction between the groups and presented to the 
patients the results from the literature for surgery in “classic” CTS; maybe some 
patients declined from surgery for that reason, which might explain the difference. 
In addition, patients were allowed to make their own decision on the treatment 
option, which might give some bias, however no statistically significant differences 
occurred between the groups of patients studied in this regard. Follow-up was done 
with a questionnaire sent by mail, which inherently means that response rate was 
not maximal. However, we tried to increase response rate by telephoning patients 
who did not respond initially. With response rates over 80% we managed to restrict 
this limitation. As a consequence, follow-up varies between 7 and 9 months after 
treatment. To compare the effect of surgical and non-surgical treatment in CTS 
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patients with sensory symptoms restricted to the median nerve area and CTS 
patients without this restriction, a randomized controlled study is needed. 
 In conclusion, no statistically significant differences in outcome were found 
between CTS patients with symptoms confined to the median nerve territory and 
patients with extramedian spread of complaints who had been clinically defined 
and electrodiagnostically confirmed as CTS patients. Patients with characteristic 
CTS complaints, but sensory symptoms involving digit 5, seem not atypical at all 
and represent a significant amount of CTS patients. Therefore clinically defined 
and electrodiagnostically confirmed CTS patients with extramedian spread of 
symptoms should not be withheld from surgical treatment. Our suggestion is to 
refrain from terms as classic or non-classic CTS. 
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Abstract
In up to 30% of patients with carpal tunnel syndrome (CTS), the cross-sectional 
area (CSA) of the median nerve may not be enlarged. We hypothesize that this 
could be the result of secondary atrophy of the nerve in severe CTS. The aim of this 
study was to measure the ultrasonographic CSA of the median nerve at the wrist in 
patients with severe CTS. 
 In 14 consecutive patients with clinically and electrophysiologically defined 
severe CTS, the CSA of the median nerve was measured and compared with that of 
control subjects. 
 CSA of the median nerve exceeded the upper limit of normal in the majority 
of patients with severe CTS. Atrophy of the median nerve in severe CTS does not 
explain negative ultrasonographic test results. Instead, the CSA of the median 
nerve is enlarged in most patients with severe CTS. 
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Introduction
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy.1 
Usually, the clinical symptoms are very characteristic, which permits a reliable 
clinical diagnosis. However, many surgeons require electrodiagnostic testing 
to confirm the diagnosis; this has a sensitivity of 85% and specificity of 95%.1 
Electrodiagnostic testing may, however, be perceived as very unpleasant by many 
patients. With respect to this, ultrasonography of the median nerve, which is 
emerging as a diagnostic test in CTS, has advantages over electrodiagnostic studies: 
it is painless, and it also gives anatomical and morphological information about 
the carpal tunnel and the nerve itself. An abnormally enlarged cross-sectional 
area (CSA) of the median nerve is a characteristic ultrasonographic finding in CTS 
and has been reported to have a sensitivity and specificity of 70-82% and 57-96%, 
respectively.2 Besides enlarged CSA, other findings can include flattening at the 
level of the hook of the hamate and an increase in CSA at the level of the pisiform 
bone compared with the CSA in the forearm.3 
 In up to 30% of patients with clinically defined CTS4 and electrophysiologically 
confirmed CTS, however, the CSA at the level of the pisiform bone is not enlarged.2 
In an old autopsy study of a patient with CTS accompanied by weakness and 
muscle atrophy, a reduction in fiber size under the flexor retinaculum was found.6 
We hypothesize that, in patients with severe CTS, the cross-sectional area of the 
median nerve is not enlarged; in fact, it may be reduced because of secondary 
atrophy of the median nerve at the carpal tunnel after severe axonal damage. 
 The aim of this study was to measure the ultrasonographic CSA of the median 
nerve at the carpal tunnel in patients with severe carpal tunnel syndrome in order 
to test our hypothesis.
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Methods
Subjects
Fourteen consecutive patients with clinically and electrophysiologically severe 
carpal tunnel syndrome were included in this observational cohort study. 
 Clinically severe carpal tunnel syndrome was considered to be present in 
patients who had pain and/or paresthesia in and restricted to the sensory 
distribution of the median nerve, with two or more of the following criteria: 1) 
nocturnal paresthesias; 2) reproduction or aggravation of paresthesias or pain by 
provocative tests (Tinel or Phalen signs); 3) aggravation of paresthesias by activities 
such as driving a car, riding a bike, holding a book, or holding a telephone; and 
4) relief of symptoms by shaking the hand. These clinical criteria have been used 
previously in other studies.6 Also, atrophy of the abductor pollicis brevis muscle 
had to be present on visual inspection and palpation of the muscle. 
 Patients with previous carpal tunnel release or carpal tunnel syndrome possibly 
caused by a traumatic injury were excluded from this study. 
 For inclusion in the study as severe CTS, patients had to have reasonably strong 
arguments for the presence of severe axonal damage of the median nerve. These 
included visible atrophy of the abductor pollicis brevis muscle exclusively, as well 
as the presence of fibrillation potentials and positive sharp waves and severe 
reduction or absence of motor unit action potentials after maximal voluntary 
effort. Patients with either normal or minimally reduced compound muscle action 
potentials (CMAPs) or sensory nerve action potentials (SNAPs) were excluded. 
Electrodiagnostic evaluation
All patients underwent standardized motor and sensory nerve conduction studies 
(NCS), as well as electromyography (EMG) of the abductor pollicis brevis muscle 
in the symptomatic hand, in accordance with our laboratory’s standard procedure 
in CTS. EMG and NCS were performed using an electromyographic device (Viking 
Myograph type IV; Nicolet Biomedial Inc., Maddison, Wisconsin). Skin temperature 
was maintained at ≥ 31.0°C.
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In all sensory NCS, the proximal electrode was placed at the first interphalangeal 
joint, and the distal recording electrode was placed at a distance of at least 3 cm, if 
feasible. Stimuli with a duration of 0.3 ms were applied .
 Sensory nerve conduction studies compare the onset latencies of the median 
nerve and the ipsilateral ulnar nerve over the same distance, recorded from the 
ring finger. The conduction velocity of the ulnar nerve should be at least 50 m/s. 
A difference in onset latency of > 0.4 ms or the absence of the median SNAP is 
considered to be consistent with CTS. In segmental sensory conduction studies 
across the wrist SNAPs were recorded from digits 2 and 3 after stimulation of the 
median nerve at the palm and at the wrist, where the palm-to-digit distance is half 
of the distance between the stimulation sites of the wrist and digit. 
 Absence of median SNAPs or a difference in conduction velocity between the 
palm-to-digit and palm-to-wrist of > 10 m/s is considered to be consistent with 
CTS. 
 Median nerve motor NCS were performed by stimulating the median nerve at 
the wrist and at the cubital fossa. CMAPs were recorded from the thenar eminence 
using surface electrodes at a distance of 6 cm from the stimulation site at the wrist. 
A distal motor latency of > 4.0 ms is considered to be consistent with CTS. 
 In addition to our standard protocol, needle electromyography of the abductor 
pollicis brevis muscle was conducted in every patient with a concentric needle 
electrode. 
Ultrasonographic evaluation 
Ultrasonographic examination was performed by an experienced electrodiagnostic 
technician, using a Philips Diagnostic Ultrasound System (model iU22) with a 
5-17 MHz linear array transducer. All wrists were examined in neutral position 
with palm up and fingers semi-extended. The median nerve was visualized about 
7 cm proximal to the carpal tunnel in longitudinal and transverse planes to confirm 
identification of the nerve. At the inlet of the carpal tunnel, which is defined as 
the proximal margin of the flexor retinaculum between the scaphoid tubercle 
and the pisiform bone, the CSA was measured using the direct tracing method. 
The distal wrist crease was used as an external landmark. The inner margin of the 
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hyperechoic sheath was considered to be the margin of the nerve. In case of a 
bifid median nerve, the CSA of the extra branch was added to the CSA of the main 
branch, because the size criterion for bifid median nerves is higher than for non-
bifid median nerves.7
 In all patients, the wrist circumference at the distal wrist crease was 
measured by a marking gauge and a measuring tape with a precision of 1 mm. 
In case of bilateral symptoms, only the most symptomatic side was examined by 
ultrasonography. Ultrasonographic examination was performed on the same day 
as the electrodiagnostic studies. The technician was blinded to the results of the 
nerve conduction studies and electromyographic examination.
 As the population of patients in this study appeared to be of rather advanced 
age, we tested an additional group of 12 healthy persons with comparable age 
characteristics. This group fitted well within the reference values for CSA of the 
original reference group.
Statistical Analysis
Data concerning clinical variables, NCS, EMG, and ultrasonography were processed 
using Microsoft Office Excel and Access 2003, and all statistical analyses were 
performed using SPSS, version 17.0. 
 Our laboratory reference values were collected previously for NCS as well as for 
quantitative ultrasonography of the median and ulnar nerves.8 By using the regression 
equations based on left/right side and circumference of the wrist, we calculated how 
the observed CSA differed from the mean of normal in order to obtain a Z-score. So, 
by definition, a Z-score of < 2 would be a normal result. The following regression 
equations were used: right side: Zright = (measured CSA – 0.86 * wrist circumference) 
/ 1.45, and left side, Z
left
 = (measured CSA – 1.06 * wrist circumference) / 1.55.9
 The Mann-Whitney U-test was used for testing differences between patients 
and controls. 
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Results
Study population
In the 14 patients evaluated, gender was equally distributed and the mean age was 
71.8 years (range 52-86 years). The median duration of symptoms was 6.0 months 
(range 2 – 24 months). See Table 1 for more detailed demographic and clinical 
features of the patients.
 Because the mean age of the patient group was relatively old in comparison to 
controls, the CSA values of the median nerve in 12 asymptomatic elderly individuals 
was determined and used as an extra, age-matched control group. 
Table 1. Clinical features
Patients
N = 14
Elderly controls
N = 12
Sex male/female 7/7 5/7
Age (mean ± SD, years) 71.8 ± 10.5 78.0 ± 5.4
Median duration of symptoms (months) 6.0 -
Wrist studied ( left/right*) 6/8 11†/12
Bifid median nerve (left/right) 1/2 2/3
Atrophy of abductor pollicis brevis muscle 14 (100%) 0
Diabetes Mellitus 4 (28.5%) 0
* Three patients had bilateral complaints compatible with carpal tunnel syndrome.
† In one asymptomatic elderly individual, only the right side was examined because of a previous traumatic 
lesion of the wrist.
Electrophysiology
In all patients, fibrillation potentials and/or positive sharp waves were found in the 
abductor pollicis brevis muscle on needle EMG examination. CMAPs were absent in 
12 patients and there was severely reduced amplitude (i.e., < 0.6 mV) in 2 patients. 
Median SNAPs were completely absent in 11 patients. 
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Ultrasonography
The overall mean CSA in patients was 17.7 mm2 (SD 5.22); 17.6 mm2 (SD 7.24) and 
17.8 mm2 (SD 3.64) for the left and right median nerve, respectively. Detailed data 
on mean CSA and mean Z-scores of the CSA are shown in Table 2. 
Table 2. Mean CSA and Z-score of the CSA of the median nerve and 95% confidence 
intervals in patients and elderly controls
Patients 
N = 14
Elderly 
N = 12
mean ± SD 95% CI mean ± SD 95% CI
Mean CSA (mm2) 17.7 ± 5.22* 14.7 – 20.7 9.92 ± 2.28 8.94 – 10.9
Mean CSA left (mm2) 17.6 ± 7.23 9.97 – 25.2 9.95 ± 2.48 8.22 – 11.6
Mean CSA right (mm2) 17.8 ± 3.64 14.7 – 20.8 9.89 ± 2.18 8.56 – 11.3
Z-score of the CSA 4.93 ± 3.40* 2.96 – 6.89 0.42 ± 1.85* -0.38 – 1.22
* p < 0.001; CSA : cross sectional area
The boxplots in Figure 1 show the spread of the Z-scores and 95% confidence 
intervals of the mean of the median nerve CSA in patients with severe CTS as well 
as in elderly controls. The boxplots in Figure 2 show the spread of the mean CSA as 
well as 95% confidence intervals, not corrected for wrist circumference. 
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Figure 2. Boxplots showing mean CSA of the median nerve
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Discussion
Previous studies demonstrated that, in CTS patients, the degree of 
electrophysiological abnormalities is associated with CSA of the median nerve at 
the wrist.9,10 To our knowledge, no such data have been published with regard to 
severe CTS with axonal damage.
 The main finding of this study is that, in severe CTS, the CSA of the median 
nerve clearly exceeds the upper limit of normal in the majority of cases (11 of 
14). This rejects our hypothesis that, in patients with severe CTS, atrophy of the 
median nerve is not an explanation for the normal ultrasonographic findings. In 3 
cases, the CSA of the nerve was within normal limits, but not one patient had a CSA 
below the lower limit of normal. We do not have a clear explanation for the normal 
ultrasonographic findings in these cases, but because the values are within normal 
ranges, one can assume there is still no clear indication for atrophy of the nerve.
In this study, the diagnosis of CTS was based on carefully defined clinical criteria, 
complemented by extensive electrodiagnostic studies. Reference values were 
derived from previous research in the same laboratory using the same equipment 
and performed by the same technician. 
 In most of the patients, motor and sensory compound action potentials were 
absent or very low. This may of course be the result of axonal damage. However, 
conduction block may contribute to this if stimulation is applied proximal to the 
zone of compression. Palmar stimulation can reliably distinguish this cause of 
low SNAPs but only in the case of second and third digit involvement. In motor 
conduction studies, palmar stimulation may be applied, yet this may cause 
unintentional stimulation of ulnar branches in the palm11 and may lead to recording 
CMAPs from ulnar-innervated muscles in the thenar eminence. We did not perform 
this test. 
 The rather small sample size is a relative limitation of our study. Nevertheless, 
differences between groups are statistically significant and numerically relevant. 
 The finding of the relatively old age of these patients is remarkable. As these 
ages lie outside our set of reference values, we measured CSA in 12 healthy 
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controls whose ages matched those of the patient group. The CSA values appeared 
to be within the range of our reference values. Therefore, the observed large CSA 
in this group of patients can not be attributed to old age. From previous reports it is 
known that severe CTS, accompanied by severe electrophysiological abnormalities, 
is more frequent in the elderly,12 and that older patients more often present with 
severe CTS accompanied by thenar atrophy.13 However, ultrasonographic findings 
have not been reported.
 Another issue worth considering is the occurrence of diabetes among these 
patients with severe CTS. In a previous study among diabetics, the mean calculated 
CSA was greater in patients with clinical evidence of diabetic polyneuropathy as 
compared with patients without polyneuropathy.14 In our study, however, patients 
with clinical evidence of polyneuropathy were not included. Moreover, SNAPs 
of the ulnar nerve were normal in all patients. After exclusion of the 4 diabetics, 
our results remained essentially the same. Further studies are needed to collect 
reference values in diabetics to be used in ultrasonography for diagnostic purposes.
 In this study, the duration of symptoms ranged from 2 to 24 months 
(median = 6 months); severe CTS with axonal damage occurred after both short- 
and long-standing complaints. 
 In conclusion, atrophy of the median nerve in clinically and electrophysiologically 
severe CTS does not explain the negative ultrasonographic test results. Instead, 
based on these results, we conclude that the CSA of the median nerve is enlarged 
in most patients with severe CTS. 
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Summary
This thesis explores current daily practice and new aspects in diagnosing and 
treating patients with complaints suggestive of carpal tunnel syndrome (CTS). The 
main conclusion of each chapter is in bold print.
 In the Netherlands, patients suspected of having a CTS are often referred to 
an outpatient neurology clinic to confirm the diagnosis of the general practitioner 
(GP). In chapter 2 results are reported of a study that we performed to investigate 
whether the clinical diagnoses of the GPs corresponded to the clinical diagnoses 
of the neurologists, and to what extend nerve conduction studies were positive 
for CTS. GPs used a specific check-list like referral letter for patients suspected of 
having a CTS. In 187 of 232 patients (81%) the neurologist agreed with the clinical 
diagnosis of CTS of the GP. Nerve conduction studies were positive for CTS in 180 
patients (78%). 
General practitioners are well capable of making a clinical diagnosis of CTS when 
they apply a specific set of criteria and therefore, direct referral of those CTS 
patients for nerve conduction studies is a desirable and time-saving procedure.
In chapter 3 data are described from a questionnaire sent to all surgeons in 
the Netherlands who operate on CTS patients. We received 324 completed 
questionnaires out of the 686 that had been sent to 110 neurosurgeons, 417 
orthopaedic surgeons and 159 plastic surgeons (an overall response rate of 47%). 
Of all neurosurgeons, 62 responded (56%), while 165 orthopaedic surgeons (40%) 
and 97 plastic surgeons (61%) returned the questionnaire. Of this group, 64% of 
surgeons stated that the majority (96 to 100%) of the CTS patients they operated on, 
underwent electrodiagnostic studies prior to surgery. Of all surgeons, the majority 
(80%) seldom or never operated on patients with a classic pattern of CTS complaints, 
if these patients showed normal electrodiagnostic study results. In neurosurgeons, 
orthopaedic surgeons and plastic surgeons, this percentage was 92%, 88% and 
59%, respectively. When these patients had a temporary relief of symptoms 
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from one or more steroid injections in the carpal tunnel, 53% of neurosurgeons, 
72% of orthopaedic surgeons and 27% of plastic surgeons would not perform 
carpal tunnel release. The different views of different groups of surgeons may be 
explained by the clinical experience in performing carpal tunnel release, which is 
broader in plastic surgeons than in most orthopaedic surgeons. Furthermore, in 
the Netherlands, neurosurgeons have an obligatory training in clinical neurology 
during their education and are probably influenced stronger by the opinion among 
neurologists that every CTS patient should undergo electrodiagnostic studies. 
In the Netherlands, in contrast to neurosurgeons and orthopaedic surgeons, 
plastic surgeons operate more often on patients with clinically defined CTS 
irrespective of electrodiagnostic study results.
We wanted to investigate the usefulness of additional measurements in 
ultrasonography of the median nerve at the carpal tunnel, and determine our 
reference values. In chapter 4 we describe our ultrasonography study in 98 wrists 
in 54 healthy control subjects without signs or symptoms of CTS. Cross-sectional 
area (CSA) of the median nerve at the inlet of the carpal tunnel was significantly 
higher in men compared to women, no significant differences were found between 
right and left wrists. Correlation studies of CSA of median nerve at the tunnel inlet 
showed significant correlation with age, gender, weight and height, but not with 
body mass index. Wrist circumference particularly showed useful correlation with 
CSA. Using linear regression equations, we found no significant difference in slopes 
between women and men and therefore regression lines were pooled. By using 
regression equations we derived normal values for upper limit of CSA based on 
left/right side and wrist circumference. Z-score was used to determine whether 
the observed CSA differed from the mean of normal. We used the following 
regression equations: Zright = (measured CSA – 0.86 * wrist circumference)/1.45 and 
Z
left 
= (measured CSA – 1.06 * wrist circumference)/1.55. A Z-score < 2 by definition 
would be a normal result.
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Measuring wrist circumference will establish the upper level of normal of CSA of 
the median nerve more accurately when compared to predictions solely based 
upon gender.
We used this new method for reference values of the upper limit of CSA of 
the median nerve taking the wrist circumference into account to compare 
electrodiagnostic confirmation of clinical diagnosis of CTS with ultrasonography. In 
chapter 5 we describe the results of this study. Out of 156 patients with clinically 
defined idiopathic CTS 83.3% met with electrodiagnostic criteria for CTS. In the 
group with normal EDX were significantly more female patients; less often they had 
weakness of the abductor pollicis brevis muscle. Ultrasonography was abnormal 
in 89 patients (57.1%) by using regression equations taking wrist circumference 
into account. Twelve patients (7.7%) had a bifid median nerve on ultrasonographic 
studies. Four of them (33.3%) had abnormal total CSA when the 2 branches of the 
bifid median nerve were added. Of 89 patients with abnormal US only 3 patients 
had normal nerve conduction studies. 
Ultrasound cannot replace electrodiagnostic examination for confirmation of the 
clinical diagnosis of CTS. Ultrasonographic studies taking wrist circumference into 
account do not have the same diagnostic value as electrodiagnostic studies in 
confirming CTS.
In chapter 6 the results are presented of our prospective cohort study to compare 
outcome results in patients with characteristic CTS complaints, but signs and 
symptoms not solely confined to the median nerve innervated area and patients 
with ‘classic’ CTS symptoms restricted to the median nerve area. All patients with 
‘non-classic’ CTS complaints presented with sensory symptoms or pain in digit 5. 
Patients with characteristic CTS complaints, but sensory symptoms involving digit 
5, seem not atypical at all and represent a significant amount of CTS patients. 
Electrodiagnostic studies were more severe in patients with symptoms only in the 
median nerve area. Outcome after 7 to 9 months was not significantly different 
between the 2 groups. Of patients presenting with symptoms restricted to the 
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median nerve area, 60.6% reported full recovery after 7 to 9 months, compared to 
48.0% in patients without this restriction (P = 0.222).
Patients with clinical characteristic CTS complaints, but not restricted to the 
median nerve innervated area and an abnormal electrodiagnostic test result 
should be treated in the same way as patients with CTS symptoms only in the 
median nerve area.
In the observational cohort study that we described earlier, we excluded patients 
with severe carpal tunnel syndrome, in order to collect a homogenous group 
of patients with idiopathic carpal tunnel syndrome. In chapter 7, we describe 
the results of an observational cohort study in 14 patients with clinically and 
electrophysiologically severe CTS. We hypothesized that in patients with severe 
CTS, the cross-sectional area of the median nerve is not enlarged on US and may 
be reduced because of secondary atrophy of the median nerve. Median duration 
of symptoms was 6 months (2 to 24 months). In these patients, CSA of the median 
nerve was measured with ultrasonography and compared to an age matched 
control group. The overall mean CSA in patients was 17.7 mm2, in elderly controls 
this was 9.92 mm2 (P < 0.001). Using linear regression equations that take wrist 
circumference into account, as described earlier, mean Z-scores of CSA in patients 
was 4.93 and in elderly controls it was 0.42 (P < 0.001). 
Atrophy of the median nerve in patients with severe CTS does not explain 
negative ultrasonographic test results. The CSA of the median nerve is enlarged 
in most patients with severe CTS.
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General discussion and perspectives
Diagnosis and treatment of carpal tunnel syndrome
The diagnosis of CTS is a clinical diagnosis based on a history of sensory complaints 
and pain in the median nerve innervated area. Presence of nocturnal paresthesia 
in the median nerve area and aggravation of complaints by holding the hand in a 
dependent position such as holding a telephone or riding a bicycle, support the 
diagnosis.1,2,3 Studies show that the incidence of CTS is increasing slightly4 and that 
there is a trend in increase in referral rate.5 Economic consequences include direct 
costs from medical management and indirect costs from absence of work. 
 Many clinicians are involved in the diagnosis and treatment of patients with 
CTS, therefore a clear and effective protocol in diagnosing and treating CTS is 
desirable. Referring patients with distinct clinical symptoms of CTS directly for nerve 
conduction studies, instead of referral to an outpatient neurology clinic, is a time-
saving and probably a cost-saving procedure. Patient visit to the hospital is then 
limited to one visit to establish the diagnosis and to decide on further treatment. 
General practitioners (GPs) are well capable of diagnosing CTS on clinical grounds 
(chapter 3). However, in 17% of referred patients, the neurologist disagreed with 
the opinion of the GP, which can most probably be explained by a more extensive 
knowledge on the differential diagnosis. 
 In order to improve clinical diagnosis of CTS by GPs, a clear questionnaire should 
be present, to increase the chance of correct referral. Others have examined the use 
of questionnaire tools in diagnosing CTS. Kamath et al. investigated the sensitivity 
of a questionnaire performed by a hand surgeon and electrodiagnostic studies 
(EDX) in patients suspected of having CTS referred by their GP.6 As a gold standard, 
symptom relief after 2 weeks was used. They found sensitivity to be 85% for the 
questionnaire, compared to 92% for EDX. They concluded that this questionnaire 
can be used by GPs, with stricter criteria (a score of more than 5 instead of 3 when 
performed by a hand surgeon) to select patients for direct referral for surgical 
decompression without the need for EDX. Others have also investigated the value 
of referral protocols for CTS.7 With the use of the check-list like referral letter (see 
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Appendix 1) by GPs, the suspected diagnoses of CTS by the GPs correspond with 
the clinical diagnoses of neurologists in 80% (chapter 3). 
 A limitation of our study is the fact that we only included patients with complaints 
within the median nerve area, excluding patients with pain or paresthesia in digit 
5. It would be interesting to know the concordance of clinical diagnosis between 
GP and neurologist in this group of patients.
– Treatment of carpal tunnel syndrome
When complaints of CTS are mild, short-lasting and do not interfere with daily 
activities or work, an electrodiagnostic confirmation of the clinical diagnosis is not 
necessary in most cases. GPs can explain the condition and implications to patients 
and advise them to make adjustments in daily activities to reduce repetitive 
movements of the wrist. Wrist splints can be prescribed to wear during the night 
and local steroid injections can relief symptoms as well.8,9 Duration of symptom 
relief with conservative treatment is relatively short. A recent review concludes 
that it remains unclear whether any conservative treatment provides a lasting 
benefit for patients with complaints of CTS. No benefit was found when comparing 
two injections versus one injection.10 It remains unclear whether conservative 
treatment can prevent, rather than delay the need for surgery in the future. When 
complaints are more severe, surgical decompression is advised. 
 Guidelines recommend performance of EDX when considering surgical 
decompression of CTS.11,12 However, among clinicians, there is debate as to whether 
EDX is necessary in typical CTS. Some clinicians state that when the probability 
of CTS is high, surgical or non-surgical treatment can be instituted safely without 
EDX.1,13,14,15 It is known that referral for and treatment of CTS varies regionally. 
Keller found incidence of surgical decompression varied within regions in the US 
from 82 to 287 per 100000 of the population.16 Also, among surgeons who operate 
on CTS, the use of electrodiagnostic studies varies.17,18 In the Netherlands, most 
CTS patients operated on, are referred by a neurologist. 
 The results of a questionnaire we sent to surgeons who operate on CTS revealed 
that most surgeons only perform surgical decompression after electrodiagnostic 
confirmation (chapter 2). However, plastic surgeons operate on patients with 
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negative EDX more often compared to neurosurgeons and orthopedic surgeons. 
This means, that the referring clinician can influence treatment by deciding to 
which surgical specialty the patient is referred. This means, that at least in the 
Netherlands, referral bias can be present in clinical studies on treatment of CTS 
patients. Whether a patient with clinically defined CTS with normal EDX undergoes 
surgery is likely to depend on the surgical discipline to which the patient is referred. 
In surgical literature, some advocate omitting the performance of neurophysiologic 
studies in patients with typical CTS complaints.13,19
 Major limitations of our study are the presence of a response bias, which is 
inherent to studies including surveys. It is likely that there are more surgeons who 
do not perform CTS surgery among the non-responders. Because the questionnaires 
were sent anonymously, we were not able to find out possible reasons for not 
responding. We did not perform formal statistical testing of the data, because of 
the obvious differences between the data. 
 
– Ultrasonography in the diagnosis of CTS
More than 20 years ago, Buchberger et al. were the first to describe the use of 
ultrasonography in diagnosing CTS.20 Since then, many research studies on 
ultrasonography in CTS have been published. Overall, the most consistent finding 
has been an increase in cross-sectional area (CSA) of the median nerve in or at the 
inlet of the carpal tunnel . Over the past years, several reviews and meta-analyses 
on this topic have been published.21,22,23 These reviews all show a variability of 
sensitivity and specificity of CSA in diagnosing CTS, with sensitivity ranging from 
44% to 95% and specificity ranging from 57% to 100%. This variability is caused by 
small sample size of study group or controls, different clinical and electrodiagnostic 
criteria for CTS and variability in cut off values for CSA (Upper Limit of Normal, CSA 
7 to 13 mm2).
 In comparison with EDX, ultrasound has lower sensitivity and specificity and 
can therefore not replace EDX in diagnosing CTS. However, ultrasound has several 
advantages compared to EDX: it provides information on the content of the carpal 
tunnel, which can be helpful pre-operatively, for instance when bifid median nerve 
is present or aberrant structures such as cysts or tumors. Many patients perceive 
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nerve conduction studies as unpleasant and sometimes painful. In contrast, 
ultrasound is an easy and completely painless examination. It also is a relatively 
cheap and quick test. 
 In comparison with most studies, the sensitivity of US for CTS in the study 
described in chapter 5 is relatively low. An explanation may be the use of a new 
diagnostic parameter in US that calculates cutoff points taking wrist circumference 
into account (chapter 4) and possibly spectrum bias: we included only patients 
with idiopathic CTS and excluded patients with severe thenar atrophy. In the group 
of control subjects described in chapter 4, we found cut off points for CSA by using 
the 95th percentile as the upper limit of normal of 11 mm2 for women and 13 mm2 
for men. Since other studies had found a correlation between CTS and different 
wrist anthropometrics such as wrist and hand size,24,25,26 we measured various 
biophysical parameters and investigated whether a possible correlation with CSA 
could be found, in order to establish the upper limit of normal more accurately. 
With the finding of a significant correlation between wrist circumference and 
CSA, we hypothesized that the upper limit of normal of median nerve CSA in 
an individual person is related to wrist circumference. By using the calculated 
regression equations that take wrist circumference into account, the upper level of 
normal of CSA can be established more accurately, compared to predictions solely 
based upon gender. 
 Possible drawbacks of our study are the relatively small size of the control 
group and the possible presence of subclinical mild distal slowing of median nerve 
because we did not perform EDX in this group. We focused on wrist circumference 
and did not measure other anthropometric data such as wrist-index. 
Ultrasonography versus electrodiagnostic studies 
– Clinically defined CTS
Using the earlier described reference method, sensitivity of US in diagnosing CTS is 
57% (chapter 5), which is relatively low in comparison to other studies.21,22 Because 
clinical diagnosis was considered the gold standard in this study and all patients 
had clinical definite CTS, specificity could not be calculated from this study. We 
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conclude that US taking wrist circumference into account only, cannot replace EDX 
for the confirmation of the clinical diagnosis of CTS. However, this method of US 
has a high positive predictive value for abnormal EDX in clinical definite CTS, as 
the chance of normal EDX in case of abnormal US test result is only 3%. When 
complaints of CTS are classic, that is, meet the following criteria: paresthesia 
or pain in the median nerve innervated area, and 2 or more major criteria: 1) 
nocturnal paresthesia, 2) positive Flick sign, 3) aggravation by driving, holding a 
book or telephone, one can consider to perform US as a first examination. In case 
of affirmative results, no further EDX would be necessary. In case of normal US 
test results, EDX is needed to confirm the clinical diagnosis, at least in cases where 
surgery is considered. It needs to be emphasized, that this is only applicable to 
patients who meet the typical clinical criteria for CTS. 
– Influence of distribution of sensory symptoms on outcome in CTS
It is known that in daily clinical practice, many patients with CTS report symptoms 
that are not considered to be ‘classic’. In particular, sensory symptoms outside 
the median nerve territory are common among CTS patients.27,28,29 Outcome of 
treatment of a cohort of CTS patients with characteristic sensory symptoms not 
exclusively restricted to the median nerve innervated area was compared to a 
cohort of patients with symptoms following the ‘classic’ distribution (chapter 6). 
The results of this study show no significant difference in outcome after 7 to 9 
months between these groups. Therefore, patients with characteristic symptoms of 
CTS, but sensory symptoms or pain outside the anatomical median nerve territory, 
should be treated in the same manner as patients with ‘classic’ symptoms, and 
should not be withheld from surgery. We suggest that these patients should not 
be referred to as atypical or non-classic CTS patients but rather a ‘variant’ CTS. 
In the literature, it is suggested that CTS in patients with an extramedian sensory 
distribution was less severe on EDX.30 In our study, EDX was more abnormal in 
patients with a median nerve distribution, however, overall severity of EDX was not 
significantly different between groups. 
 We did not randomize patients for surgical or non-surgical outcome. In order to 
compare results of conservative versus surgical treatment, a randomized controlled 
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study is needed. A possible limitation of our study is the exclusion of patients with 
polyneuropathy or diabetes mellitus, who could be more likely to present with CTS 
complaints in an extramedian distribution. Further study is needed to investigate 
this specific group of patients. 
 Follow-up was done with a questionnaire sent by mail, which inherently means 
that the response rate was not maximal. However, we tried to increase response 
rate by telephoning patients who did not respond initially, and sending a new 
questionnaire. With response rates over 80% we managed to restrict this limitation. 
As a consequence, follow up varies between 7 to 9 months after treatment. 
– Severe CTS
In our observational cohort study we excluded patients with severe thenar 
atrophy, indicating the presence of severe CTS because of the intention to examine 
a homogenous population of patients with idiopathic CTS. As stated earlier, US 
sensitivity in diagnosing CTS varies and this leaves a significant amount of CTS 
patients with normal CSA of the median nerve at the site of compression. Previous 
studies have shown that severe CTS with more severe electrophysiological 
abnormalities, is more frequent in elderly people.31 It is also known, that elderly 
patients more often present with thenar atrophy.32 We hypothesized that in 
patients with severe CTS, median nerve CSA is not enlarged because of secondary 
atrophy of the median nerve. Although the study (chapter 7) included a relatively 
small group of 14 patients, the results are significant and show that the mean CSA 
in patients with severe CTS is significantly enlarged compared to an elderly control 
group. Therefore, the hypothesis is rejected and median nerve atrophy does not 
explain negative ultrasonographic test results. 
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Recommendations and direction for future research
General practitioners are well capable of a clinical diagnosis of CTS. However, using 
a check-list like referral letter with clear clinical criteria is useful to select patients 
that can be examined directly in a neurophysiology department. An example of 
such a referral letter, as used in our study, is shown in the appendices. 
 Considering current guidelines on treatment of CTS and the preference of 
surgeons to operate only after confirmation of the clinical diagnosis of CTS, it can 
be concluded that nowadays CTS patients that are being considered for operative 
treatment, should undergo some sort of diagnostic confirmation. Ultrasonography 
and EDX are complementary in providing information on the function and anatomy 
of the median nerve and characteristics of the surroundings of the carpal tunnel 
in the wrist. Earlier studies have clearly shown the usefulness of ultrasound in 
diagnosing CTS. However, usage in daily clinical practice is limited, because of 
unclear cut-off points and exact location of measurement. Because of different 
design and cut-off points, sensitivities and specificities vary. Every neurophysiology 
department using ultrasound in CTS patients, needs to establish its own normal 
values. Furthermore, interobserver agreement needs to be established more 
clearly. CSA of the median nerve is dependent on wrist anthropometrics and can 
vary among different ethnic patient groups around the world. In future studies, 
more information on the ethnic background of included patients is desirable. By 
using wrist circumference in defining ULN in a patient, variation of CSA as a result 
of patient characteristics can be reduced. In patients with clinically defined CTS, 
ultrasonography using wrist circumference to outline upper limit of normal, is a 
reliable tool in confirming the clinical diagnosis. As this is a new diagnostic tool in 
ultrasound, further randomized trials are needed. When ultrasonographic studies 
are normal, EDX should be performed in CTS patients with complaints that justify 
surgical treatment.
 Previous studies demonstrated that, in CTS patients, the degree of electro-
physiological abnormalities is associated with CSA of the median nerve at the 
wrist.33,34 It would be interesting to investigate results of ultrasonographic studies 
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in patients with symptoms confined to the median nerve area and patients with 
extramedian spread of symptoms. 
 Treatment strategy in CTS patients is dependent on the referral behaviour of the 
neurologist who refers the patient for operative treatment. In patients with normal 
electrodiagnostic study results, ultrasonography can contribute to establishing 
diagnosis more accurately and this deserves further study. Further study is needed 
in patients with normal EDX and clinical definite CTS complaints. Most surgeons 
are reluctant to operate on these patients without diagnostic confirmation. It is 
in this specific group of patients, that ultrasonography can play an important role. 
Randomized trials are needed to confirm the diagnostic value of ultrasonography 
in these patients. 
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Inleiding 
Het carpale tunnelsyndroom (CTS) is de meest voorkomende drukneuropathie 
en wordt veroorzaakt door compressie van de nervus medianus in de carpale 
tunnel. De diagnose wordt gesteld op basis van de anamnese en het neurologisch 
onderzoek en wordt vaak bevestigd door middel van zenuwgeleidingsonderzoek. 
De behandeling bestaat uit conservatieve maatregelen zoals een nachtelijke 
polsspalk of lokale corticosteroïdinjectie in de carpale tunnel, of chirurgische 
behandeling middels decompressie volgens een open of endoscopische procedure. 
Het CTS heeft een belangrijke invloed op het dagelijks functioneren van mensen 
en daarmee een grote maatschappelijke en economische impact. Reeds tientallen 
jaren wordt een toename gezien in de herkenning en doorverwijzing van het aantal 
patiënten met verdenking CTS door onder andere huisartsen. 
 In het algemeen vindt men dat de diagnose carpale tunnelsyndroom op grond 
van de klachten en klinische verschijnselen betrouwbaar kan worden gesteld. 
In veel richtlijnen wordt echter ter bevestiging van de klinische diagnose aan-
vullend zenuwgeleidingsonderzoek geadviseerd voordat operatieve behandeling 
wordt overwogen. Echter, elke vorm van hulponderzoek en dus ook het zenuw-
geleidingsonderzoek kent vals positieve en vals negatieve uitkomsten en kan 
daarom niet als de zogenoemde gouden standaard voor de diagnose CTS worden 
beschouwd. Hierdoor bestaat er discussie over de noodzaak voor dergelijk onder-
zoek in de dagelijkse praktijk. Een nieuw en gemakkelijk uitvoerbaar diagnostisch 
onderzoek is de zenuwechografie. De diagnostische waarde hiervan wordt op vele 
plaatsen nog onderzocht, maar zenuwechografie wordt nu al wel in de dagelijkse 
praktijk in toenemende mate toegepast. 
 In dit proefschrift worden de dagelijkse klinische praktijk, de waarde van aanvul-
lende diagnostiek en het effect van de behandeling van patiënten met de diagnose 
CTS beschreven. De belangrijkste conclusies van ons onderzoek zijn steeds vet 
gedrukt.
 In hoofdstuk 1 worden de achtergronden en aanleiding voor het onderzoek 
beschreven.
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In Nederland worden patiënten verdacht voor een CTS veelal verwezen naar een 
polikliniek neurologie of klinische neurofysiologie om de diagnose te bevestigen. 
In hoofdstuk 2 worden de resultaten beschreven van een studie die we uitvoerden 
om te onderzoeken in hoeverre de klinische diagnose, zoals gesteld door de 
huisarts, overeenkomt met de diagnose van de neuroloog en in welke mate 
zenuwgeleidingsonderzoek de klinisch gestelde diagnose CTS bevestigt. Huisartsen 
gebruikten een specifieke vragenlijst als verwijsbrief voor patiënten met klachten 
passend bij een CTS. In 187 van 232 patiënten (81%) was de neuroloog het eens met 
de klinische diagnose CTS zoals gesteld door de huisarts. Zenuwgeleidingsonderzoek 
bevestigde de diagnose CTS in 180 patiënten (78%). In de appendix vindt men een 
geanonimiseerd voorbeeld van de gebruikte vragenlijst.
Wanneer gebruikt gemaakt wordt van een specifieke vragenlijst blijken huis-
artsen de klinische diagnose CTS accuraat te stellen. Directe verwijzing door hen 
van deze patiënten voor bevestiging van de diagnose met behulp van zenuw-
geleidingsonderzoek is derhalve een betrouwbare en tijdbesparende procedure. 
In hoofdstuk 3 worden de bevindingen beschreven van een enquête, die verstuurd 
werd naar alle chirurgen in Nederland die CTS patiënten opereren. We ontvingen 
324 ingevulde vragenlijsten retour van de 686 vragenlijsten die gestuurd werden 
naar 110 neurochirurgen, 417 orthopedische chirurgen en 159 plastisch chirurgen 
(totale respons van 47%). Van de neurochirurgen antwoordden er 62 (56%), terwijl 
165 orthopedisch chirurgen (40%) en 97 plastisch chirurgen (61%) de ingevulde 
vragenlijst terugstuurden. In deze groep gaf 64% van de chirurgen aan, dat de 
meerderheid (96-100%) van de CTS patiënten die ze opereerden, ter bevestiging 
van de diagnose CTS zenuwgeleidingsonderzoek had ondergaan voorafgaand 
aan de operatie. Van alle chirurgen opereerde de meerderheid (80%) zelden 
of nooit patiënten met typische CTS klachten, wanneer de diagnose CTS niet 
door zenuwgeleidingsonderzoek bevestigd kon worden. Voor neurochirurgen, 
orthopedisch chirurgen en plastisch chirurgen was dit percentage respectievelijk 
92%, 88% en 59%. Indien deze patiënten een tijdelijk effect bemerkten van 1 
of meerdere lokale corticosteroïdinjecties in de carpale tunnel, gaven 53% van 
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neurochirurgen, 72% van orthopedisch chirurgen en 27% van plastisch chirurgen 
aan geen operatie uit te voeren. De verschillen in de mening van de verschillende 
groepen chirurgen zouden verklaard kunnen worden door de ervaring in uitvoering 
van operatieve decompressie van de nervus medianus in de carpale tunnel, die 
groter is bij plastisch chirurgen dan bij orthopedisch chirurgen. Daarnaast hebben 
neurochirurgen in Nederland een verplichte stage neurologie in hun opleiding 
tot specialist, waardoor ze meer specifieke kennis hebben en mogelijk ook meer 
beïnvloed worden door de mening van neurologen, dat de diagnose CTS door 
zenuwgeleidingsonderzoek zou moeten worden bevestigd. 
In vergelijking met neurochirurgen en orthopedisch chirurgen opereren 
plastisch chirurgen in Nederland vaker patiënten met de klinische diagnose CTS 
onafhankelijk van resultaten van zenuwgeleidingsonderzoek.
 
De laatste jaren wordt er veel onderzoek verricht naar echografie bij aandoeningen 
van perifere zenuwen. De techniek en nauwkeurigheid van echografie is enorm 
verbeterd en hierdoor kunnen zenuwen steeds beter in beeld worden gebracht. 
Bij het carpale tunnel syndroom blijkt bij een deel van de patiënten sprake van een 
verdikking van de nervus medianus ter hoogte van de carpale tunnel (Figuur 1 en 
2). 
 We wilden onderzoeken wat de waarde van echografie is bij de diagnostiek van 
het carpale tunnelsyndroom. Daarvoor is het van belang eerst normaalwaarden 
voor dit onderzoek te bepalen. In hoofdstuk 4 beschrijven we de resultaten van een 
studie naar de zin van een nieuwe methode van aanvullende metingen bij echografie 
van de nervus medianus. Met deze methode werden onze normaalwaarden 
bepaald. Negenentachtig polsen van 54 gezonde proefpersonen zonder klachten of 
tekenen van CTS werden echografisch onderzocht. De oppervlakte van de nervus 
medianus ter hoogte van de ingang van de carpale tunnel was significant hoger in 
mannen in vergelijking met vrouwen. Er werd geen significant verschil gevonden 
tussen links en rechts. Correlatiestudies toonden een significante correlatie tussen 
de oppervlakte van de zenuw met leeftijd, geslacht, lichaamsgewicht en lengte, 
maar niet met de body mass index. Met name de polsomtrek toonde een duidelijke 
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Figuur 1. Echografie van normale nervus medianus ter hoogte van de carpale tunnel
Figuur 2. Echografie van verdikte nervus medianus ter hoogte van de carpale tunnel
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correlatie met de oppervlakte van de nervus medianus. Er werd geen significant 
verschil gevonden in de curven voor mannen en vrouwen, waardoor data van 
deze beide groepen samengevoegd konden worden. Door middel van lineaire 
regressievergelijkingen werden normaalwaarden gevonden voor de maximale nog 
normale oppervlakte van de nervus medianus gebaseerd op de polsomtrek links 
of rechts. We gebruikten de Z-score om aan te geven of een gemeten oppervlakte 
afwijkt van het gemiddelde. De volgende regressievergelijkingen werden gebruikt: 
Zrechts = (gemeten oppervlakte – 0.86 * polsomtrek)/1.45 en Zlinks = (gemeten 
oppervlakte – 1.06 * polsomtrek)/1.55. Een Z-score kleiner dan 2 betekent per 
definitie een normaal resultaat.
Met gebruik van de polsomtrek kan de maximale nog normale oppervlakte van 
de nervus medianus in een individuele patiënt nauwkeuriger bepaald worden in 
vergelijking met afkapwaarden alleen gebaseerd op geslacht. 
Met de op deze wijze verkregen normaalwaarden werd de diagnostische waarde 
van het zenuwgeleidingsonderzoek vergeleken met die van de zenuwechografie in 
patiënten met de klinisch gestelde diagnose CTS. In hoofdstuk 5 worden de resultaten 
van dit onderzoek beschreven. Van 156 patiënten met een klinisch gedefinieerd 
idiopathisch CTS had 83.3% een afwijkend zenuwgeleidingsonderzoek passend 
bij CTS. De groep met een normaal zenuwgeleidingsonderzoek bevatte significant 
meer vrouwen, die minder vaak spierzwakte vertoonden van musculus abductor 
pollicis brevis. Echografisch onderzoek was afwijkend in 89 patiënten (57.1%) 
volgens de methode die gebruik maakt van de regressievergelijking en polsomtrek. 
Echografie toonde een bifide medianus (gesplitste zenuw ter hoogte van de carpale 
tunnel) aan bij 12 patiënten (7.7%). Vier van deze patiënten (33.3%) hadden een 
afwijkende oppervlakte van de zenuw indien de oppervlakte van de 2 afzonderlijke 
takken werd opgeteld. Van 89 patiënten met een afwijkend echografisch onderzoek, 
hadden slechts 3 patiënten een normaal zenuwgeleidingsonderzoek. 
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Echografisch onderzoek van de nervus medianus blijkt, ook als men rekening 
houdt met de polsomtrek, niet dezelfde diagnostische waarde te hebben als 
zenuwgeleidingsonderzoek in de bevestiging van de diagnose CTS. Daarom kan 
echografisch onderzoek het zenuwgeleidingsonderzoek niet vervangen om de 
klinische diagnose carpale tunnel syndroom te bevestigen.
In hoofdstuk 6 worden de resultaten gepresenteerd van het prospectieve cohort 
onderzoek dat we uitvoerden om de uitkomst van behandeling te vergelijken tussen 
de groep patiënten met “klassieke” CTS klachten en de groep met “niet-klassieke” 
CTS klachten. Met “niet-klassieke” CTS klachten wordt hier bedoeld, dat de 
klachten zich ook voordoen buiten het door de nervus medianus verzorgde gebied 
en dan met name ook in de vijfde vinger, waarvan het gevoel wordt verzorgd door 
de nervus ulnaris. Alle patiënten met het ‘niet-klassieke’ klachtenpatroon hadden 
klachten in de vijfde vinger. Patiënten met typische CTS klachten, die ook klachten 
en eventueel verschijnselen hebben in de vijfde vinger, vormen een belangrijk 
deel van de CTS patiënten en worden soms ‘atypisch’ genoemd. Het resultaat van 
behandeling na 7 tot 9 maanden werd onderzocht. Het bleek dat patiënten met 
klachten wel, respectievelijk niet beperkt tot het innervatiegebied van de nervus 
medianus in 60.6% respectievelijk 48.0% volledig herstel rapporteerden. Dit 
verschil was statistisch niet significant (P = 0.222).
Patiënten met een klinisch gedefinieerd en door zenuwgeleidingsonderzoek 
bevestigd CTS, die ook verschijnselen in de vijfde vinger hebben, dienen op 
dezelfde manier te worden behandeld als CTS patiënten bij wie de verschijnselen 
strikt beperkt zijn tot het innervatiegebied van de nervus medianus. 
In het eerder beschreven observationeel cohort onderzoek werden patiënten 
met een zeer ernstig CTS uitgesloten, met als doel een zo homogeen mogelijke 
groep patiënten met een idiopathisch CTS te verzamelen. In hoofdstuk 7 worden 
de bevindingen van een observationele cohort studie in 14 patiënten met klinisch 
en neurofysiologisch ernstig CTS beschreven. We toetsten de hypothese dat de 
nervus medianus niet verdikt is ter hoogte van de carpale tunnel bij patiënten 
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met een ernstig CTS ten gevolge van secundaire atrofie van de zenuw. De mediane 
duur van symptomen was 6 maanden met een spreiding van 2 tot 24 maanden. 
Bij deze patiënten werd de oppervlakte van de nervus medianus gemeten met 
behulp van echografie en vergeleken met een wat de leeftijd betreft bijpassende 
controlegroep. De gemiddelde oppervlakte in de totale groep patiënten was 
17.7 mm2 en in de controlegroep 9.92 mm2 (P < 0.001). Gebruikmakend van lineaire 
regressievergelijkingen die de polsomtrek in acht nemen zoals eerder beschreven, 
was de gemiddelde Z-score van de oppervlakte van de nervus medianus in de 
patiënten 4.93 en in de controlegroep 0.42 (P < 0.001). 
Atrofie van de nervus medianus in patiënten met ernstig CTS biedt geen verklaring 
voor normale bevindingen bij echografisch onderzoek van de nervus medianus in 
deze groep patiënten. De oppervlakte van de nervus medianus is vergroot in de 
meerderheid van patiënten met een ernstig CTS. 
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Vragenlijst
Een geanonimiseerd voorbeeld van een vragenlijst voor verwijzende huisartsen, 
zoals gebruikt in het onderzoek.
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Abbreviations 
APB abductor pollicis brevis muscle
BMI body mass index
CMAP  compound muscle action potential
CSA cross sectional area
CTS carpal tunnel syndrome
DML distal motor latency
EDX electrodiagnostic examination
EM ellipse method
FSS   functional status score
GP general practitioner
NCS nerve conduction study
NCV nerve conduction velocity
SNAP sensory nerve action potential
SSS   symptom severity score
TM tracing method 
ULN upper limit of normal na TM
US ultrasonography
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wel goed zou komen, ook als ik dat even niet zo zag. Het is ontzettend leuk te weten 
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is en dat ons onderzoek de fundamenten hiervoor mede heeft gelegd. Wim, je 
snelheid van denken en scherpe inzicht zijn indrukwekkend. Jan, dank voor de fijne 
en leerzame tijd tijdens de stage klinische neurofysiologie. Onderwijs geven is een 
kunst, en die beheers jij als geen ander. Dank voor de ruimte en tijd die jullie mij 
gaven na het beëindigen van mijn opleiding tot neuroloog, om het onderzoek te 
combineren met het werk in de dagelijkse praktijk. 
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niet minder belangrijk. Veel dank voor de bereidheid deze taak op u te nemen en 
dank voor de nuttige tips en commentaren. 
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deel te nemen en voor het lezen en beoordelen van het manuscript. 
 Mijn paranimfen Kristel Kasius en Angelique Sijben. Kristel, erg dankbaar ben ik 
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Dank dat je één van mijn paranimfen wil zijn en dank voor je support al die jaren. 
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